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ABSTRACT
The highly contaminated St. Lawrence Estuary beluga whale (SLB) population 
exhibits health problems and various pathologies possibly associated with pollutant 
exposure, which are not found in less exposed Canadian Arctic belugas (CAB). 
Biotransformation mediates contaminant fate and effects through conversion to less 
persistent, more excretable products (detoxification) and through formation of 
retained/persistent, secondary contaminants (bioactivation). In this thesis, the metabolic 
potential o f  these two differentially exposed beluga populations towards PCBs and 
PBDEs was investigated. Qualitatively similar hepatic xenobiotic-metabolizing enzyme 
profiles (cytochromes P4501A, 2B, 3A, 2E, epoxide hydrolase and UDP-glucuronosyl 
transferase) were immunochemically detected between SLB and CAB, indicating that 
CAB can be used to model contaminant biotransformation in the endangered SLB. Viable 
SLB and CAB microsomes exhibited catalytic activities characteristic of CYP1A 
(ethoxyresorufin-Q-deethylase, 51 to 260 pmol/mg/min), CYP3A (6p~testosterone 
hydroxylase, 113 to 899 pmol/mg/min) and UDPGT (1 -naphthylglucuronidase, 830 to 
4956 pmol/mg/min), but not o f CYP2B. Residue analysis revealed retained PCB and 
PBDE metabolites in SLB and CAB livers. Sum- (X-) hydroxy- (HO-) PCB and Z- 
methylsulfonyl- (MeSCh-) PCB concentrations were significantly greater in SLB (65 ± 22 
and 3801 ± 1322 ng/g lipid) than in CAB (3.1 ± 0.5 and 77 ± 23 ng/g lipid). HO-PBDE 
congeners were detectable, but below the MLOQ in both populations. Different congener 
profiles and significantly higher Z-PBDE (2210 ± 656 cf. 53 ± 16 ng/g lipid) and Z-PCB 
(31 937 ± 6498 cf. 1939 ± 436 ng/g lipid) were also found in SLB versus CAB, 
respectively. A model CAB individual demonstrated CYP-mediated oxidative
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
metabolism o f ortho-meta unsubstituted BDE 15, BDE28 and BDE47 in vitro. PCBs 
that are putative CYP1A substrates (CB15, CB77) were more rapidly metabolized in 
vitro than CYP1 A/CYP2B-type (CB26, CB31), which were depleted faster than CYP2B- 
type (CB52). Water-soluble metabolites of CB15 and BDE 15 were detected. Weight of 
evidence (enzyme characterization, liver analysis, in vitro metabolism) indicated an 
oxidative biotransformation pathway for PCBs and PBDEs in belugas. These results 
suggest contaminant bioactivation through formation of retained/persistent and 
potentially toxic PCB (and possibly PBDE) metabolites. Evidence o f possible 
bioactivation mechanisms via biotransformation supports the association between 
contaminant exposure and health problems in the endangered SLB population.
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LIST O F  ABBREVIATIONS
Ab antibody
AHH aryl hydrocarbon hydroxylase
AhR aryl hydrocarbon receptor
BDE# bromodiphenyl ether, numbered according to Ballschmiter and Zell
(1980)* rales for polychlorinated biphenyls 
BFR brominated flame retardant
BROD benzyloxyresorufin O-deethylase
CAB Canadian Arctic beluga whale
CB# chlorobiphenyl, numbered according to Ballschmiter and Zell
(1980)*
CHL chlordane
CYP cytochrome P450 isozyme





GC-ECD gas chromatography-electron capture detection






HO-PBDE hydroxy-polybrominated diphenyl ether
HO-PCB hydroxy-polychlorinated biphenyl
HPC halogenated phenolic contaminant
HPLC high-performance liquid chromatography
IS internal standard
MeO-PBDE methoxy-polybrominated diphenyl ether
MeO-PCB methoxy-polychlorinated biphenyl
MeSG2-PCB methyl sulfonyl polychlorinated biphenyl
MFO mixed function oxidase
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PBDE polybrominated diphenyl ether
PBT persistent bioaccumulative toxin
PCB polychlorinated biphenyl
PROD pentoxyresorufin O-deethylase
SIM selected ion monitoring
SLB St. Lawrence beluga whale
ti/2 halflife
T4 thyroxine
TIC total ion current
TTR transthyretin
UDPGT uridine diphosphoglucuronosyl transferase
* Ballschmiter, K., Zell, M., 1980. Analysis of polychlorinated biphenyls (PCB) by glass 
capillary gas chromatography. Fresenius J. Anal. Chem. 302, 20-31.




Contamination of the environment and its inhabitants by anthropogenic organic 
chemicals has been occurring since the early twentieth century, but especially in the mid­
twentieth century when chemical manufacturers began large scale production o f a whole 
range o f chemicals useful to industry and society. For instance, fe-2,2-(4-chlorophenyl)-
1,1,1 -trichloroethane (DDT) was discovered as an insecticide in 1939 and 
polychlorinated biphenyls (PCBs) began their commercial use mainly as electrical 
insulators in 1929. Intentional distribution and accidental release to the environment lead 
to the subsequent presence o f these chemicals, now referred to as persistent organic 
pollutants or persistent bioaccumulative toxins (PBTs), in humans and in wildlife 
(Lipnick and Muir, 2001). Years after the imposition o f severe restrictions limiting the 
production and/or release of many o f these “traditional” PBTs, they continue to be found 
in the environment and in biota, and research continues to provide new and varied 
evidence o f their toxicological effects (e.g. Goldey et al, 1995; Kelce et ah, 1995; Kester 
et al., 2 0 0 0 ).
The currently unrestricted release o f polybrominated diphenyl ether (PBDE) 
flame retardants, close structural analogues o f PCBs, has lead to their widespread
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environmental distribution (Damerud et al, 2001). PBDE levels are exponentially 
increasing in humans and in wildlife, particularly in North America (Hites, 2004), 
indicating a major new environmental contamination problem (de Boer et al., 1998).
1.1 PCBs
There are theoretically 209 different PCB isomers and congeners, consisting o f 1 
to 10 chlorine substituents around a biphenyl ring system (Fig. 1.1). PCBs were produced 
in North America solely by the Monsanto Company, with all but perhaps 10% of the 
possible congeners present in commercial mixtures (de Voogt and Brinkman, 1989). The 
first report o f PCBs in biota, specifically in fish and birds, was published nearly forty 
years after PCBs were first used commercially (Jensen, 1966). In 1969, Jensen et al. 
reported PCBs in marine mammals as well, while studying grey seals (Halichoerus 
grypus) and ringed seals (Phoca hispida) from the Baltic Sea. These and many 
subsequent studies evidenced the persistent, bioaccumulative and toxic properties of 
PCBs, which lead to their ban in both Canada and the USA by 1977.
1.1.1 Persistence and distribution
In addition to numerous accidental spills and contaminations (e.g. Higuchi, 1976), 
PCBs have been and continue today to be released into the North American environment 
mainly through, for instance, leakage from currently used products and also from landfills 
(Tanabe, 1988). After entering the environment, PCBs may undergo cyclic volatilization 
to the atmosphere followed by deposition to terrestrial and aqueous media, resulting in 
their long-range transport (Ballschmiter, 1991). Although an excellent property for their
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Fig. 1.1. General chemical structures of PCBs and PBDEs and related metabolites.
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intended usage, the relative inertness of PCBs in various environmental media 
(Ballschmiter, 1991) and in biological systems (Tanabe et al., 1988) results in their slow 
degradation. For these reasons, PCBs and other organochlorine contaminants are globally 
distributed in the environment, from the Arctic (Addison and Smith, 1974; Norstrom and 
Muir, 1988, Muir et al., 1992) to the Antarctic (Sladen et al., 1966; Subramanian et al., 
1983, 1986) and all latitudes in between (Holden and Marsden, 1967; Gaskin et al., 1971, 
1974; Tarasuki et al., 1975). PCBs are also ubiquitous in the marine mammal 
populations of the world (Tanabe, 1983).
Suggesting future continued contamination o f marine environments, it was 
predicted in 1988 that only around 30% of the total PCBs produced (estimated at about 
106 tonnes globally by de Voogt and Brinkman (1989)) had thus far made it to the 
environment (Tanabe, 1988), and that only 3% of this had yet made it to the oceans 
(Marquenie and Reijnders, 1989). In addition, there are indications that cold regions at 
latitudinal extremes act as ultimate sinks for organic contaminants (Wania and MacKay, 
1993), implicating the particular vulnerability o f the Arctic and species therein to 
anthropogenic organic contamination. As evidence, over the last few decades PCB 
concentrations have tended to be steady or decreasing in cetacean and pinniped species 
inhabiting regions o f mid-latitude (Baltic Sea, North Sea, northwest Atlantic Oceans), but 
steady or increasing in those populations of species inhabiting polar regions (west Arctic 
Ocean, Antarctic Ocean) (Aguilar et al., 2002).
Nonetheless, marine mammals from temperate latitudes that are closer to PCB 
sources, such as Baltic seals and St. Lawrence beluga whales, currently still exhibit 
elevated lipid-corrected levels o f PCBs than their conspecifics from more remote regions
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(Muir et al., 1996; Metcalfe et al., 1999; Nyman et al., 2001, 2003). For instance, in the 
late 1980s concentrations of PCBs and DDT-related compounds were reported to be 15- 
to 30-fold higher in SLB adipose tissue than in adipose o f their Arctic counterparts in 
Cumberland Sound, western Greenland, Beaufort Sea and Hudson Bay (Muir et al., 
1996). In brain, liver and muscle tissues o f SLB, PCB concentrations were found to be 
13, 11 and 11 times higher, respectively, than in beluga whales from Hendrickson Island 
in the Canadian Arctic (CAB) (Metcalfe et al., 1999). The PCB and DDT levels in SLB 
adipose tissues are both more than 15 fold higher than those found in beluga whales from 
Svalbard, Norway (Andersen et al., 2001).
1.1.2 Bioaccumulation and biomagnification
PCBs meet the three requirements for bioaccumulation. They are bioavailable, 
slowly metabolized and slowly excreted (Sijm, 2001). Upon deposition in marine and 
other aqueous environments, PCBs readily bioconcentrate in organisms at low trophic 
levels directly from water due to their hydrophobic nature (Thomann, 1989). As PCB 
levels are then higher in biological systems than in the surrounding media, food chain 
transfer, along with absorption and storage, o f these and other OCs has resulted in their 
elevated levels in top predators (biomagnification) (Norstrom and Muir, 1994). In 
addition, the tendency to partition into fatty tissues decreases PCB mobility in an 
organism and further increases biological persistence (Jones and de Voogt, 1999).
The large lipid stores (blubber) in, and longevity of, marine mammals confers a 
predisposition o f these species to accumulate organic contaminants (Colbom and Smolen, 
1996). Indeed cetaceans, particularly piscivorous species, have elevated levels o f PCBs in
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comparison to other exposed organisms, such as birds, humans, and other terrestrial 
mammals (Tanabe et al., 1988). In an Arctic marine food chain, X-PCB showed a 
biomagnification factor o f 1.5 from zooplankton (Calanus spp.) to cod [Boreogadus 
saida) and 24.4 from fish to beluga whale (Hoekstra et al., 2003). Metabolism is 
nonetheless a major factor mediating the bioaccumulation and toxicity o f such 
contaminants (Sijm, 2001), as is discussed in detail later in this introduction. Moreover, 
the apparently lower metabolic capacity of beluga whales and other cetaceans has been 
suggested as a reason for greater PCB biomagnification in these species in comparison to 
other marine and terrestrial mammals (Tanabe, 1988; Norstrom and Muir, 1994).
1.1.3 Toxic effects
In PCB-exposed laboratory animals, thyroidogenic, estrogenic and androgenic 
effects have been reported, as well as related neurobehavioural, reproductive and 
developmental toxicities (Ulbrich and Stahlmann, 2004). Deleterious health effects have 
been reported in wildlife, generally in high trophic level organisms that have been 
chronically exposed to PCBs and other OCs over their lifetimes. Although definitive 
cause-effect linkages cannot be drawn, there have been some major health and survival 
issues documented in marine mammal populations since the 1960s, which many suggest 
may be related to pollutant exposures (Tanabe, 2002). The main putative toxic effects 
have been immunological dysfunction and resulting infectious diseases, reproductive 
im pairm ent, as well as mass strandings and/or mortalities.
Many recent outbreaks o f infectious viral diseases in various marine mammal 
populations have resulted in thousands o f deaths (De Guise et al., 2003). Because these
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populations have been highly contaminated, and chronic exposure o f PCBs to laboratory 
animals has lead to greater susceptibility to viral outbreak, Eis (1989) suggested that 
organochlorine exposures may be a factor in these mass mortalities. Immunotoxicity o f 
PCBs has been demonstrated in many experimental organisms, but there is a dearth o f 
such studies in marine mammals (De Guise et al., 2003). A study was done on pinnipeds, 
wherein harbour seals (Phoca vitulina) that were fed environmentally contaminated 
Baltic herring, versus less contaminated herring, exhibited various impairments in 
immune functioning (de Swart et al., 1994). Lahvis et al. (1995) found a negative 
correlation between blood levels o f OCs and lymphocyte proliferation in free-ranging 
bottlenose dolphins (Tursiops truncatus). PCB mixtures, at levels found in St. Lawrence 
beluga whales, caused reduced leukocyte cell proliferation in beluga studies in vitro, also 
supporting the role o f OC-mediated immunological dysfunction in cetaceans (De Guise et 
al., 1998).
Similar to studies of immunotoxicity, many reproductive and developmental 
disorders have been documented in marine mammals, but few have been linked to 
contaminant exposures. Olsson et al. (1994) suggested that high rates o f sterility in 
female Baltic grey and ringed seals (30 and 70%, respectively) were associated with PCB 
and DDT metabolites. OC exposure has also been suggested to be related to testes 
abnormalities in minke whales (Balaenoptera acutorostrata) (Fujise et al., 1988) and 
premature births in Californian sea lions (DeLong et al., 1973). Reijnders (1986) found 
that seals fed PCB contaminated fish exhibited reproductive failure.
These immunological and reproductive pathologies may be related to the 
endocrine disrupting and metabolic activating potential o f PCBs. The immune system is
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regulated, in part, by estrogens and androgens (Grossman, 1985), which are better known 
as reproductive hormones. Thyroid hormones, part of the endocrine system, influence 
immune function as well as cellular differentiation, growth, metabolism and 
reproduction. Harbour seals fed PCB contaminated fish, showed depleted thyroid 
hormone and vitamin A levels (Brouwer et al., 1989). Negative correlations between 
PCB levels and various steroid hormone levels have been found in harbour seals 
(Reijnders, 1999) and Dali’s porpoises (Phocoenoides dalli) (Subramanian et al., 1987).
Interactions o f some PCBs with metabolic enzyme systems have been reported in 
some marine mammals. In beluga whales from the MacKenzie River Delta in the 
Canadian Arctic, there was a strong correlation between immunodetectable cytochrome 
P450 (CYP) 1A and adipose levels o f ort/zo-substituted coplanar PCB congeners (White 
et al., 1994), suggesting induction o f the CYP1A enzyme by these PCBs. Higher 
CYP 1 A-mediated ethoxyresorufin O-deethylase (EROD) activity was measured in 
contaminated Baltic seals than that measured in seals from reference sites (Nyman et al., 
2003). EROD and PROD (pentoxyresorufin O-deethylase) activities were correlated to 
PCB tissue residue levels in northern fur seals near Japan (Tanabe et ah, 1994). It is 
important to consider that the role o f metabolism and PCB metabolites is unclear in many 
of the correlative studies o f PCB toxicity in wildlife. However, some o f the toxic effects 
that have been associated with PCBs have been documented in experimental animals 
dosed with persistent hydroxylated- (HO-) PCB and methylsulfonyl- (MeSOa-) PCB 
metabolites (Fig. 1.1, discussed later).
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1.2 PBDEs
Polybrominated diphenyl ethers are structurally similar to PCBs, except that an 
ether linkage separates the two biphenyl rings and chlorine atoms are replaced by 
bromine atoms (Fig. 1.1). PBDEs are the most commonly used brominated flame 
retardant (BFR) additives to polymeric materials, such as textiles and electronics 
equipment. When heated, bromine atoms released from the compounds react reductively 
to slow the progression o f fires. Unlike PCBs, only a handful o f congeners are present in 
the technical formulations, commercially distributed as the Penta- (a mixture of mainly
2.2 ’ ,4,4 ’ -tetra-BDE (BDE47) and 2,2 ’ ,4,4 ’ ,5-penta-BDE (BDE99) and minor amounts of 
2,4,4’-tri-BDE (BDE28), 2,2’,4,4’,6-penta-BDE (BDE100), 2,2’,4,4’,5,5’-hexa-BDE 
(BDE153) and 2,2’,4,4’,5,6’-hexa-BDE (BDE154)), Octa- (mainly 2,2’,3,4,4’,5’,6-hepta- 
BDE (BDE183) and BDE153) and Deca- (mainly the fully brominated deca-BDE 
(BDE209)) mixtures. These BFRs are manufactured in North America primarily by the 
Great Lakes Chemical Corporation (Indianapolis, IN) and also by Albemarle Corporation 
(Richmond, VA).
Environmental contamination was first discovered when Anderson and Blomkvist
(1981) found PBDEs in fish from Sweden. Similar persistent, bioaccumulative and toxic 
properties to PCBs have lead to a ban on the Penta- and Octa-mixtures in the EU and a 
voluntary stop-production on the Penta- and Octa- formulations by Great Lakes Chemical 
by the end of 2004. However, there are currently no restrictions on usage/release/disposal 
of PBDEs in most o f the United States or in Canada. As well, there is no ban on the labile 
deca-BDE, which may be converted to persistent, bioaccumulative lower brominated 
congeners (see below).
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1.2.1 Persistence and distribution
PBDEs are released into the environment from manufacturing facilities, landfills 
and leaching from products in use (Damerud et al., 2001). From air to waters and 
sediments to wildlife, PBDEs have been found in virtually all abiotic and biotic media 
sampled in various regions of the world (de Boer et al., 2000). In fact, PBDEs have been 
detected in deep-sea dwelling sperm whales, implying that PBDE contamination has 
made it to the deep waters of the oceans (de Boer et al., 1998). These data and long-range 
transport models (Wania and Dugani, 2003) imply that PBDEs are now ubiquitously 
distributed throughout the world, akin to PCBs.
Also like PCBs and other PBTs, PBDEs are generally found at higher 
concentrations in marine mammals inhabiting temperate locales, which are highly 
industrialized and populated with humans, than in Arctic animals (Lebeuf et al., 2004). In 
the most recent year with data from both regions, 1997, St. Lawrence beluga whales had 
more than 20 fold higher adipose X-PBDE levels (lipid weight basis) than belugas from 
the eastern Canadian Arctic (Cumberland Sound) (Law et al., 2003). Unlike the 
traditional PBTs, however, PBDE levels have been increasing exponentially in most 
humans and wildlife sampled over the past 30 years (Hites, 2004). In fact, the time it 
takes for PBDE concentrations to double in mid-latitude marine mammals is just around 
5 years. For Arctic marine mammals, the doubling time is slightly but not significantly 
higher at around 7 years (Hites, 2004).
PBDEs persist in the environment (de Boer et al., 2000). de Boer et al. (1998) 
suggested that PBDEs are even more biologically persistent than PCBs based on slow
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metabolism of BDE47, 99 and 209 in an in vitro assay with one fish and four marine 
mammal species. However, the higher lability o f carbon-bromine bonds versus carbon- 
chlorine bonds may result in greater importance of environmental and/or metabolic 
reductive dehalogenation pathways for the degradation o f PBDEs (WHO, 1994). This is 
particularly likely for highly brominated congeners which have been shown to degrade 
rapidly under UV light in various media (Eriksson et al., 2004). For BDE209, the halflife 
(ti/2) was just 30 min in 80:20 methanokwater. In Sweden, where there has been a trend 
towards alternative flame retardants, there is some evidence from human milk data that 
PBDE concentrations may already be starting to decrease (Meironyte-Guvenius et al., 
2001; Lind et al., 2003). PBDE levels in North America, in contrast, are rapidly 
increasing (Hites, 2004; Ryan, 2004). Regardless, continued escape from already 
manufactured products and the abiotic and biotic stability o f some congeners alludes to 
the potential for long-term environmental issues with PBDE contamination.
1.2.2 Bioaccumulation and biomagnification
Akin to PCBs, the hydrophobic PBDEs tend to concentrate on particulate matter 
and in biota (de Boer et al., 2000). This bioaccumulation appears to be structure-specific. 
The dominant congener in biota is almost always BDE47, with BDEs 99 and 100 also 
representing a major portion o f the X-PBDE concentrations. This pattern does not mimic 
that o f the commercial PentaBDE formulation or o f that found in sediments (Fig. 1.2). 
Elevated biological levels o f BDE47 may be related to more rapid uptake or to 
biotransformation of higher brominated congeners (e.g. BDE99) (Stapleton et al., 2004a).
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Fig. 1.2. PBDE congener patterns in North America and Europe expressed as a 
percentage o f X-PBDE for the Penta product (black bars), sediment (grey bars) and non- 
Arctic marine mammals (seal, porpoise and whale species) (white bars). The error bars 
represent ± S.E. Modified from Hale et al. (2001) and Hites (2004).
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Given that DecaBDE is produced in the largest quantities globally (Hites, 2004), lower 
bioavailability and possible metabolic conversions, as seen in rat (Morck et al., 2003), 
may explain the low levels o f BDE209 in biota. Gustaffson et al. (1999) found that BDEs 
47 and 99 were bioaccumulated in blue mussels to a much greater extent than PCBs of 
similar hydrophobicity, indicating the comparable or higher bioaccumulation potential for 
PBDEs versus PCBs.
Wolkers et al. (2004) showed that BDEs 47, 99 and 100 biomagnify from cod to 
beluga whale in an Arctic (Svalbard) foodchain. BDE154, though, did not appear to be at 
higher levels in beluga in comparison to cod, suggesting some metabolism of this 
congener in beluga whale. Marine mammals from temperate latitudes (seals, porpoises 
and whales from North America and the UK) generally exhibit elevated PBDE levels in 
comparison to humans (Hites, 2004) and other terrestrial mammals (Damerud et al., 
2001). These data suggest that as for PCBs and other OCs, relative to other biota, marine 
mammals species may be most susceptible to PBDE contamination and biological effects. 
Although metabolic potential may be a major factor in the vulnerability of marine 
mammals towards PCB accumulation, there is hardly sufficient data on the metabolic and 
excretory capacity of any marine mammals towards PBDEs (Hakk and Letcher, 2003).
1.2.3 Toxic effects
The apparent similitude between PBDEs and the more thoroughly studied and 
better understood PCBs (i.e. chemical structure, lipophilicity, stability) suggests that 
these two classes of pollutants may share mechanisms o f toxic action and/or effects. 
Indeed, PBDEs do exhibit some of the previously mentioned toxicities of PCBs, at least
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in laboratory organisms. Commercial PBDE and PCB mixtures (Bromkal 70-5DE and 
Aroclor 1254, respectively,) have shown immunotoxic effects, such as reduced 
splenocyte numbers, in mice (Damerud and Thuvander, 1999). In rats, however, effects 
were only seen with the PCB formulation. Meerts et al. (2001) demonstrated that a 
number o f PBDE congeners act as xenoestrogens in an in vitro human cellular assay 
(>106 fold less agonistic than 17(3-estradiol, the natural ligand), but that some HO-PBDE 
congeners demonstrated even greater estrogenic potency than 17(3-estradiol. In both rats 
and mice, in vivo PBDE exposure resulted in decreased thyroid hormone levels (Fowles 
et al., 1994; Damerud and Sinjari, 1996). In another human cell-based assay, PBDEs did 
not compete with the thyroid hormone thyroxine (T4) for the transport protein 
transthyretin (TTR). However, certain HO-PBDE congeners were potent competitors 
(Meerts et al., 2000). HO-PBDE congeners that are structurally similar to T4 (i.e. one 
phenyl ring, a HO-group para to the ether linkage, and bromine atoms on carbons 
adjacent to the para-carbon with the HO-group) exhibit greater thyroidogenic activity 
than HO-PCBs. In addition, PBDEs appear to be developmental neurotoxicants in 
laboratory rodents (Erikkson et al., 2002; Viberg et al., 2003).
There are varied reports o f the enzyme inducing ability o f PBDEs towards CYP 
and phase II activities. Induction o f EROD, MROD (methoxyresorufin O-deethylase), 
especially PROD, and phase II UDPGT was seen in laboratory rats orally dosed with 
BDE47 (Hallgren and Damerud, 1998). Chen et al. (2001) also found EROD induction 
by a few environmentally unimportant PBDE congeners in rat, chick, rainbow trout and 
human hepatocytes, but not by BDE47 or BDE99. Also, Zhou et al. (2002) showed 
EROD, PROD and UPDGT induction in rats treated with DE-71 and their offspring.
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However, environmentally relevant congeners (BDEs 47, 99, 100, 153, 154, and/or 183) 
have not elicited EROD induction in fish (Boon et a l, 2002) or human cell lines (Peters 
et al., 2003).
Despite this data from experimental animals, virtually no data exists on PBDE 
toxicokinetics or potential biological effects in marine mammals. There is but a single 
report o f PBDE toxicity in a pinniped species. Hall et al. (2003) found a significant 
positive relationship between adipose PBDE levels in grey seal pups and thyroid 
hormone concentrations, unlike the negative relationship seen in laboratory rodents. The 
authors suggest that this may be due to hormesis (Calabrese and Baldwin, 2003), wherein 
the homeostatic imbalance is overcompensated for by elevated production of thyroid 
hormones at low PBDE levels. Clearly, the mechanism(s) of action and toxic effects of 
PBDEs in marine mammals require further study.
1.3 Biotransformation
The biological fate of a contaminant depends on uptake, distribution, metabolism, 
and excretion. Biotransformation influences the residence time of a contaminant in an 
organism through catalytic formation of more hydrophilic and thus more readily 
excretable metabolites. This process should primarily result in the detoxification o f PBTs. 
However, metabolism may be a bioactivation process leading to the formation of retained 
metabolites that are toxicologically active. Thus, not only the toxicokinetics, but also the 
inherent toxicity o f a compound depends on metabolic capacity.
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I.3.1 Phase 1 and I I  reactions
Biotransformation reactions are categorized into phase I and phase II processes. 
Foreign compounds that are able to enter cells and bind to proteins are generally small, 
neutral and lipophilic (Stine and Brown, 1996). Therefore in phase I, xenobiotics are 
oxidized, hydrolyzed or reduced to less hydrophobic, more reactive metabolites. In phase
II, these metabolites are conjugated to larger, hydrophilic endogenous molecules or ions, 
which are then readily excreted from an organism.
The phase I cytochromes P450 (CYP) are a superfamily o f heme-based enzymes 
found in mammals, fish, birds and microorganisms. In mammals, the highest CYP 
activity is in the smooth endoplasmic reticulum of the liver. Most foreign compounds, 
including environmental pollutants, drugs and antibiotics, as well as endogenous 
compounds, such as steroids, bile acids, fatty acids and prostaglandins are biotransformed 
by CYP enzymes (Goksoyr and Forlin, 1992; Stegeman and Hahn, 1994; Lewis et al., 
1998, 2002). CYP1A, CYP2B, CYP3A, CYP2E and epoxide hydrolase (EH) are major 
enzymes mediating the phase I metabolism of anthropogenic compounds (Nebert et al., 
1991). The main phase II enzyme systems are the glutathione-S-transferases (GSTs), 
uridine diphosphoglucuronosyl transferases (UDPGTs) and sulfo-transferases (SULTs) 
(George, 1994; Wolkers et al., 1998). GSTs mediate the conjugation of glutathione to 
arene epoxide bearing phase I intermediates. UDPGTs and/or SULTs mediate the 
conjugation o f glucuronic acid and 3'-phosphoadenosine-5'-phosphosulfate (PAPS), 
respectively, to the HO-group of phenols, for instance. Although these processes were 
previously thought o f as detoxifying, it is now known that for many organic
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contaminants, intoxication may be the result of biotransformation (e.g. polycyclic 
aromatic hydrocarbons, PAHs) (Stine and Brown, 1996).
The induced and constitutive levels o f individual CYP and phase II enzymes are 
species- and population-specific (Boobis et al., 1990; Smith, 1991). For marine 
mammals, particularly cetaceans, there are limited reports o f immunochemical or 
catalytic characterizations of metabolic potential. For instance, enzymes cross-reactive 
with CYP1A, CYP2B and CYP2E antibodies have been determined in beluga whales 
(White et al., 1994, 2000; Wilson et al., 2000). CYP 1 A-mediated 7-ethoxyresorufin (O- 
deethylase activity, EROD) and benzo[a]pyrene (aryl hydrocarbon hydroxylase activity, 
AHH) activities have also been reported in belugas from the MacKenzie River Delta in 
the Canadian Arctic (White et al., 1994, 2000). A more comprehensive study of phase I 
and II enzyme expression and activity is needed to assess the metabolic capacities o f 
beluga whales, particularly from differentially exposed populations, towards potentially 
toxic, environmental xenobiotics.
1.3.2 PCBs
Boon et al (1994, 1997) devised a classification scheme for the oxidative 
metabolism o f PCBs in marine mammals. This categorization was based on the congener 
patterns among species of marine mammals and comparisons to the patterns in prey 
species (i.e. fish). In cetaceans, several features o f the general PCB congener pattern 
(ratio to CB153) were observed: (1) congeners with vicinal H atoms, a property found to 
increase metabolic rates in laboratory animals, were depleted in comparison to other 
congeners, (2) congeners with vicinal ortho-meta H atom pairs were significantly lower
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than in fish and (3) congeners with vicinal meta-para H atom pairs were similar to that in 
fish (Boon et al., 1992). In seals, the findings were similar, except that congeners with 
vicinal meta-para H atom pairs were also depleted in comparison to fish. This difference 
may be accounted by the fact that cetaceans appear to have lower CYP2B type activities 
than pinnipeds. On the basis o f these results, PCBs were classified into six metabolic 
groups (Table 1.1). Nonetheless, these CYP isozyme activities towards PCBs are only 
inferred from relative tissue concentrations. For many marine mammal species enzymes 
that mediate the metabolism of specific PCB congeners have not yet actually been 
characterized.
Patterns o f parent PCBs in tissues are only suggestive o f metabolic activity and 
capacity, but the presence of retained metabolite residues in these tissues provides direct 
evidence. Although oxidative phase I metabolites of PCBs, HO-PCBs, have not yet been 
determined in beluga whales, these phenolic metabolites have been found in some 
cetaceans (Bennett et al., 2003; Hoekstra et al., 2003) and pinnipeds (Jansson et al., 1975; 
Bergman et al., 1994). HO-PCBs have also been detected in other mammals, humans, 
fish and birds (Klasson-Wehler et al., 1998; Asplund et al., 1999; Meironyte-Guvenius et 
al., 2002; Campbell et al., 2003; Hoekstra et al., 2003; Li et al., 2003a; Letcher et al., 
2004; Sandala et al., 2004), suggesting the general presence o f these secondary 
contaminants in biota.
The CYP-mediated conversion of PCBs to HO-PCBs proceeds by either arene 
epoxide formation and subsequent ring opening or by direct HO-insertion on the biphenyl 
ring (Letcher et al., 2000a). HO-PCBs are not likely bioaccumulated, but are retained in 
biota due to an affinity for TTR that can be up to ten times greater than o f thyroxine.
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Table 1.1. PCB metabolic classification scheme for marine mammals. Modified from 
Boon et al. (1994, 1997). The proposed metabolism refers to homologues o f rat CYPs, as 











I none none - recalcitrant
II V none 2  or more recalcitrant
III V - 0  or 1 CYP1A
IV - 2  or less CYP2B/3A
V - ✓ 3 or more CYP2B/3A
VI ✓ 1 or less CYP1A/2B/3A
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These metabolites thus appear to be localized mainly in blood, but distribution in other 
tissues is less well studied (Letcher et al., 2000). In general, only HO-PCBs formed from 
persistent, higher chlorinated parent PCBs with the HO-group in the para- or sometimes 
meta-position are retained, whereas most HO-PCBs are readily conjugated and 
eliminated. In laboratory rodents, it has been demonstrated that these metabolites are 
thyroidogenic due to competitive binding to TTR and disturbance o f thyroid hormone 
metabolism (Brouwer et al., 1986). As well, HO-PCBs altered vitamin A levels in rats 
(Brouwer et al., 1986). Some o f these toxicities were seen in seals fed PCB contaminated 
fish, suggesting the role o f metabolites in PCB toxicity in marine mammals (Brouwer et 
al., 1989). van den Hurk et al. (2002) found that HO-PCBs, especially those with meta- 
para unsubstituted sites, inhibited phase II sulfation and glucuronidation activities in 
channel catfish (Ictaluris punctatus). Inhibition o f thyroxine sulfation has been shown in 
rats in vitro, suggesting another mechanism o f HO-PCB action which may be related to 
the documented developmental neurotoxic effects of PCBs (Schuur et al., 1998).
Indirect evidence for CYP2B-type biotransformation in beluga whales comes 
from the detection o f another group of persistent PCB metabolites, MeSCh-PCBs, in both 
SLB and CAB blubber tissues (Letcher et al., 2000b). In this case, PCB metabolism starts 
with the CYP-mediated formation of an arene epoxide, followed by conjugation to 
glutathione. A thiol (-SH) derivative is formed, then methylated (-SCH3), and finally 
oxidized (-SOCH3 or -SO2CH3) (Mio and Sumino, 1985). Methyl sulfone metabolites of 
PCBs have also been detected in other whale species (Haraguchi et al., 1989; Troisi et al., 
1998; Hoekstra et al., 2003), seals (Jensen and Jansson, 1976; Letcher et al., 1998), 
porpoises (Troisi et al., 1998; Karlson et al., 2000; Chu et al., 2003) as well as in humans
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and birds, but at barely above the detection limits in most fish species (Letcher et ah, 
2000a). MeSCh-PCBs are hydrophobic enough to be persistent and bioaccumulate in fatty 
tissues. Many of these congeners are resistant to metabolism, and may also be 
preferentially retained in the liver (particularly 3 -MeSCh-congeners) due specific protein 
binding. In general, the biologically retained congeners are meta- or para-MeSOj- 
substituted, resulting in a pair o f isomers, with chlorine substitution on the MeSCL- 
containing ring at the 2,5- or 2,5,6-positions. As well, these metabolites tend to have 3 to 
7 chlorine atoms in all, with one chlorine atom occupying the para-position on the non- 
MeSCb-substituted ring (Letcher et al., 2000a). MeSCb-PCBs have been shown to affect 
enzyme activities and exhibit endocrine disrupting properties. 3 -MeSC>2-PCBs were 
strong inducers o f CYP2B/2C/3A-type activities in vivo in rats; however, 4 -MeSC>2-PCBs 
were not (Kato et ah, 1995a,b). Some 3- and 4 -MeS0 2 -PCBs reduced thyroid hormone 
levels in rats (Kato et ah, 1998) and elicited reproductive dysfunction in mink in vivo 
(Lund et ah, 1999).
PCB metabolism and metabolite formation in marine mammals has more recently 
also been assessed in a limited number o f studies through the use o f in vitro phase I 
biotransformation assays. Studies have measured depletion of PCB-15, 2,7-
dichlorodibenzodioxin and 1,2,3,4,8 - pentadibenzofuran in sperm whale (Boon et ah, 
2001) and PCB depletion in grey seal (Li et ah, 2003b) and ringed seal hepatic 
microsomes (Letcher et ah, 1998). White et ah (2000) quantified the transformation of 
two PCB congeners in beluga and pilot whale liver microsomes: CB77, which is a 
CYP1A substrate in rat, and CB52, which is a phenobarbital-inducible type CYP2B 
substrate in rat. For CB77, mono-HO-PCB metabolites were detected. However,
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depletion and metabolite formation of a broad range metabolically-relevant PCB 
congeners, including those which may be parent compounds to retained HO-PCBs, has 
not been examined in any marine mammal species.
1.3.3 PBDEs
Limited data exists regarding the metabolism of PBDEs in marine mammals. 
Residue patterns in higher trophic organisms are nonetheless suggestive o f metabolism 
(Boon et al., 2002; Ikonomou et al., 2002; Wolkers et al., 2004). For instance, BDE100 
appeared to be relatively depleted in comparison to prey species in both harbour seal 
(Boon et al., 2002) and ringed seal (Wolkers et al., 2004). HO-BDEs and MeO-BDEs 
have been reported as residues in fish (Haglund et al., 1997; Asplund et al., 1999; Letcher 
et al., 2003; Marsh et al., 2004). MeO-BDEs have also been found in ringed seal and 
beluga whale (Haglund et al., 1997; Wolkers et al., 2004). There is one report o f HO- 
BDEs in the blood plasma o f an individual killer whale (Bennett et al., 2004). Several 
tetrabrominated HO-PBDE congeners were very recently found in the plasma of 
snapping turtles (Chelydra serpentina) and several species o f benthic- and pelagic- 
feeding fish species from the Detroit River area of the Great Lakes (Chu et al., 2004; 
Valters et al., 2004). There is currently a debate as to whether HO-/MeO-BDE residues 
found in marine biota are natural products or are the result o f PBDE metabolism. 
Although HO-PCBs are not known to occur naturally, some o f the ortho-substituted HO- 
/MeO-BDEs found in Baltic salmon are known to be produced by marine sponges and 
algae (Marsh et al., 2004).
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The possibility that PBDEs may undergo biotransformation processes as the 
structurally related PCBs, such as via pathways leading to HO-metabolite formation, is 
supported by  the findings in laboratory rodents and some fish species (Hakk and Letcher, 
2003). 6 m  and Klasson-Wehler (1998) showed that low levels o f HO-metabolites were 
detected in the liver and lung o f rats orally dosed with BDE47. Higher amounts of 
metabolites, five HO-tetraBDEs and two HO-triBDEs, were detected in mouse liver in 
the same study. Trace levels of HO-BDE metabolites were retained in the livers of rats 
dosed with BDE99 (Hakk et al., 2002). In addition, tetra- and penta-brominated HO-BDE 
metabolites were found in fecal extracts. Recently, evidence of the formation o f HO- 
metabolites from BDE100 has also been shown in rat (Hakk et al., 2004). Some evidence 
of sulfur-containing metabolites was also shown in these two studies. Metabolism of 
BDE209 to hydroxylated and lower brominated metabolites has also been found in orally 
dosed rats (Morck et al., 2003). Thus, akin to PCBs, PBDEs are oxidatively metabolized 
to HO-metabolites, but unlike PCBs, PBDEs are also subject to dehalogenation reactions 
in laboratory rodents. Kierkegaard et al. (2001) found HO-metabolites in northern pike 
(Esox lucius) fed food spiked with BDE47. Carp (Cyprinus carpio) were fed food spiked 
with either BDE 99, 183 or 209, and the formation o f lower brominated BDEs was 
observed (Stapleton et al., 2004b,c). In contrast, de Boer et al. (1998) did not find 
evidence for metabolism o f BDE47, 99 nor 209 in a 90 min in vitro assay using harbour 
seal, whitebeaked dolphin, sperm whale and minke whale microsomes.
The involvement o f specific xenobiotic-metabolizing enzymes in the metabolism 
of PBDEs is suggested by a single study. Meerts et al. (2000) found that PBDEs did not 
effectively compete with T4 for TTR in an in vitro assay. However, the metabolic
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products o f  PBDEs incubated prior with CYP2B induced rat liver microsomes, were 
strong competitors for TTR  binding, suggesting the involvement o f CYP2B in the 
metabolic formation of HO-PBDEs in rat. The finding of marine mammal CYP isozymes 
with substrate specificity similar to rat CYP2B would suggest the metabolic potential of 
these species towards PBDEs.
As mentioned, limited toxicological data indicates that, at least in human in vitro 
studies, HO-PBDEs exert strong thyroidogenic (Meerts et al., 2000), as well as estrogenic 
effects (Meerts et al., 2001).
1.4 Canadian beluga whale populations
1.4.1 St. Lawrence Estuary beluga whales
The isolated population o f beluga whales living in the estuary o f the St. Lawrence 
River near Quebec, Canada was listed as “Endangered” (COSEWIC, 1983, 1997) and is 
currently listed as “Threatened” (COSEWIC, 2004). Current estimates o f St. Lawrence 
beluga (SLB) population size are in the range of 900 to 1200 individuals (Kingsley, 1999; 
Gosselin et al., 2001). The population appears to be stable in size (Gosselin et a l , 2001; 
Michaud and Beland, 2001), having not rebounded in number since it was decimated 
during commercial exploitation that ended in the 1930s (Reeves and Mitchell, 1984). The 
St. Lawrence River connects the North American Great Lakes, one o f the most highly 
industrially and agriculturally contaminated regions of the world, to the Atlantic Ocean. 
Exposure and body burdens o f organic pollutants, particularly PCBs and DDT, in the 
SLB population are elevated not only in comparison to other St. Lawrence marine
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mammal species, but also in comparison to animals from other D. leucas populations 
(Muir et al., 1996; Metcalfe et al., 1999; Lebeuf et al., 2004).
Toxicological studies o f contaminants in marine mammals have often focused on 
this highly exposed St. Lawrence River Estuary population. Chronic lesions, high 
occurrences o f neoplasms and indications o f reproductive and immune dysfunction were 
found in a nine year epidemiological study of necropsied St. Lawrence beluga whales 
(Beland et al., 1993). As well, PCBs and other OCs were measured at levels above those 
known to elicit similar toxic effects in laboratory animals. A link has been suggested 
between these health issues in SLB and OC exposures (Martineau et al., 1994; De Guise 
et al., 1995).
1.4.2 Arctic beluga whales
All beluga whales, with the exception o f those from the SLB population, inhabit 
Arctic regions. The Arctic populations are from (1) Svalbard, (2)
Bering/Chukchi/Okhotsk Seas, (3) Canadian high Arctic/Greenland and (4)
Hudson/James Bay. Tissue PCB and other organochlorine levels in Arctic beluga whales 
are significantly lower than those found in SLB (Metcalfe et al., 1999; Andersen et al., 
2001; Law et al., 2003); moreover, none o f the aforementioned pathologies or 
impairments reported in SLB were found in belugas from Arctic regions (Beland et al., 
1993). However, declines in some populations have been seen, generally due to
overhunting (COSEWIC, 2004). The western Hudson Bay population, studied in this
thesis, numbers around 24 000 to 48 000 (Richard, 1993). This population was listed as
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“Not At Risk” by COSEWIC (1993), but is now listed as o f “Special Concern” 
(COSEWIC, 2004).
1.5 Thesis Objectives
The study of metabolism as a factor in organohalogen accumulation and toxicity 
is particularly relevant for marine mammals (especially cetaceans) given their elevated 
exposures, high capacity for accumulation, and potentially unique metabolic potential. 
The aim o f this thesis is to investigate the biotransformation capacity o f beluga whales 
from two differentially exposed populations towards PBDEs and PCBs. Ethical and 
logistical considerations prevent direct dosing studies on cetaceans. Therefore, an 
alternative “weight o f evidence” approach from three separate studies was used to 
examine the possible role of metabolism in the toxicological risks of PCB and PBDE 
exposures to these beluga whales. The three separate sub-objectives were as follows:
1) To determine metabolic potential towards PCBs and PBDEs via expression o f hepatic 
phase I and II enzymes of probable importance in mediating xenobiotic metabolism in 
beluga whales. To examine possible enzyme expression differences between SLB, a 
population highly exposed to enzyme-inducing contaminants, and the less exposed CAB 
(Arviat area o f western Hudson Bay).
2) To examine indirect evidence o f metabolism through analysis o f PCB and PBDE 
congener residue profiles, and direct evidence through analysis o f putative 
retained/persistent metabolite residues in SLB and CAB liver tissues. To investigate
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differential metabolic capacity between SLB and CAB suggested by liver contaminant
profiles.
3) To directly investigate the biotransformation of specific PCB and PBDE congeners 
and HO-PCB/-PBDE metabolite formation in a model CAB using an in vitro microsomal 
assay.
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CHAPTER 2
Characterization and Profiling of Hepatic Cytochromes P450 and Phase 
II Xenobiotic-Metabolizing Enzymes in Beluga Whales {Delphinapterus 
leucas) from the St. Lawrence River Estuary and the Canadian Arctic1"
2.1 Introduction
Marine mammals are particularly susceptible to contamination by organohalogens 
due to their large lipid reserves, relatively long life spans and elevated positions in the 
aquatic food web. A small, isolated and endangered population o f beluga whales 
{Delphinapterus leucas) inhabits the St. Lawrence (SL) Estuary in Quebec, Canada, an 
area downstream of many sources o f industrial and agricultural contaminants. 
Polychlorinated biphenyls (PCBs), organochlorine pesticides and other organohalogen 
contaminants have been detected in SL beluga tissues (e.g. Martineau et al., 1988; Muir 
et al., 1996; Gauthier et al., 1998; Metcalfe et al., 1999; Hickie et al., 2000; Hobbs et al., 
2003) not only at elevated levels in comparison to Canadian Arctic (CA) belugas 
(Norstrom and Muir, 1994; Metcalfe et al., 1999), but also at levels known to elicit toxic
*M.A. McKinney, A. Arukwe, S. De Guise, D. Martineau, P. Beland, A. Dallaire, S. Lair, 
M . Lebeuf, R.J. Letcher, 2004. Aquat. Toxicol. 69, 35-49.
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effects in laboratory animals (Beland et al., 1993). A link has been suggested between 
tissue organochlorine levels and the health o f the SL population (Martineau et al., 1994). 
Reproductive and immunological impairment and a high incidence of neoplasms are all 
strongly associated with pollutant exposure (De Guise et al., 1995).
Metabolic capacity is an important determinant in the bioaccumulation, 
biomagnification, toxicokinetics and potential toxicity o f lipophilic organohalogen 
contaminants. The cytochrome P450 monooxygenases (CYPs) play a central role in the 
oxidative biotransformation (phase I) o f a wide range of xenobiotic and endogenous 
compounds (Goksoyr and Forlin, 1992; Stegeman and Hahn, 1994; Lewis et al., 1998). 
Products from phase I metabolism are conjugated to larger endogenous molecules via 
catalytic mediation by phase II enzymes such as glutathione-S-transferase (GST) and 
uridine diphosphoglucuronosyl transferase (UDPGT) (George, 1994; Wolkers et al., 
1998). Phase I and II enzymes, most abundant in hepatic tissues, may transform lipophilic 
compounds into either detoxified or bioactivated forms. As there are qualitative and 
quantitative differences in the levels and inducibility o f individual CYP isozymes among 
species and populations of species (Boobis et al., 1990; Smith, 1991), it is important to 
determine the ability o f exposed animals to metabolically influence the toxicokinetics and 
fate o f accumulated anthropogenic contaminants. There is limited documentation on the 
metabolic capacity o f marine mammals towards xenobiotic compounds, and most reports 
are from seal populations of various species (Boon et al., 1992; Nyman et al., 2001). 
However, immunochemical characterization o f CYP isozymes has been reported for 
some whale species and populations, mainly for families from the odontocete suborder. 
White et al. (1994, 2000) found homologues o f CYP1A, CYP2B and CYP2E in the liver
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of CA beluga (White et al., 1994, 2000) and a CYP1A isoform has been characterized in 
various tissues of SL beluga (Wilson et a l, 2000). CYP IB, CYP3A-like and CYP4A 
isozymes have been discovered in striped dolphin (Stenella coeruleoalba), pilot whale 
(Globicephala melas), minke whale (Balaenoptera acutorostrata) and/or sperm whale 
(Physeter macrocephalus) (Goksoyr et al., 1988, 1989; Goksoyr, 1995; Celander et al., 
2000; Godard et al., 2000; Boon et al., 2001). In beluga, catalytic characterization has 
been limited to CYP 1 A-mediated EROD, PROD, MROD (7-ethoxy-, pentoxy- and 
methoxyresorufm 0-deethylase, respectively) and AHH (aryl hydrocarbon hydroxylase) 
activities (White et al., 1994, 2000; Addison et al., 1998). These studies rely on 
enzymatically-active hepatic tissues, but in contrast to laboratory specimens, it is often 
difficult to obtain well-preserved, enzymatically-viable tissues from stranded free- 
ranging animals. Therefore, catalytic activity as a quantitative indicator o f metabolic 
potential is questionable in situations where liver preservation cannot be assured. 
Immunological profiling is a more robust technique to measure phase I and II enzymes, 
providing suitably cross-reactive Ab interactions are found. On the other hand, 
immunochemical characterization is not necessarily fully representative o f existing 
protein profiles as identification depends on the constitutive and induced levels, and on 
the cross-reactivity o f the selected antibodies for specific microsomal proteins (Goksoyr, 
1995; Letcher et al., 1996; Lewis, 2000).
To more completely determine the metabolic potential o f beluga whale, a more 
comprehensive assessment is required o f hepatic xenobiotic-metabolizing enzymes in 
individuals from populations of contrasting exposure to contaminants that are capable o f 
enzyme induction or suppression. In the present study, major phase I and II isozymes,
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CYP1A, CYP2B, CYP3A, CYP2E, EH and UDPGT, known to be involved in xenobiotic 
metabolism, were immunologically and catalytically characterized in the hepatic 
microsomes of belugas from the SL (tissue collected from stranded individuals) and from 
the Arviat region of western Hudson Bay in the Canadian Arctic (fresh tissue collected as 
part of native subsistence hunting). The results were used to evaluate the use of 
immunologic expression and catalytic activity o f xenobiotic-metabolizing enzymes in the 
optimally preserved liver of beluga from a CA population as a model of metabolic 
potential in SL and other beluga populations.
2.2 Materials and Methods
2.2.1 Reagents
Bovine serum albumin (BSA), Coomassie Brilliant Blue G-250, potassium 
chloride, sodium dithionite, L-ascorbic acid, phenazine methosulfate, 7-ethoxyresorufm, 
resorufin, sodium dodecyl sulfate (SDS), bromophenol blue, 4-chloro-1 -naphthol, Brij- 
58, 1 -naphthol, 1-naphthyl P-D-glucuronide sodium salt and uridine 5'-
diphosphoglucuronic acid trisodium salt were purchased from Sigma (St. Louis, MO, 
USA). Disodium ethylenediaminetetraacetate (Na2EDTA), acrylamide/bisacrylamide 
solution (30% w/v, monomer to cross-linker ratio o f 37.5:1), ammonium persulfate, 
N,N,N',N'-tetramethylenediamine (TEMED), f3-mercaptoethanol, glycine, 
polyoxyethylene sorbitan monolaurate (Tween-20) and gelatin were acquired from Bio- 
Rad Laboratories (Mississauga, ON, Canada). Dithiothreitol (DTT), glycerol, 95% 
ethanol, 85% phosphoric acid, sodium dihydrogen phosphate, HPLC grade methanol, 
concentrated HC1, NaOH pellets and hydrogen peroxide (30% w/v) were obtained from
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EM Science (Gibbstown, NJ, USA). HPLC-grade dichloromethane and acetonitrile were 
obtained from Merck (Darmstadt, Germany). Sodium chloride and P-nicotinamide 
adenine dinucleotide phosphate (NADPH) reduced, tetrasodium salt were acquired from 
Fluka (Buchs, SG, Switzerland). NADPH regenerating system solutions A (NADP+, 
glucose-6 -phosphate, MgCL) and B (glucose-6 -phosphate dehydrogenase) were supplied 
by Gentest (Woburn, MA). Tris(hydroxymethyl)-aminomethane was purchased from 
Aldrich (Milwaukee, WI, USA). Dipotassium hydrogen orthophosphate (K2HPO4) was 
obtained from BDH Chemicals (Toronto, ON, Canada). Carbon monoxide was procured 
from BOC (Mississauga, ON, Canada). Testosterone, androstenedione, 2a-, 6 a-, 6 p-, 7 a- 
, lip*, 15a-, 16a- and 16p-hydroxytestosterone were obtained from Steraloids (Wilton, 
NH). Water was supplied by a Milli-Q system (Millipore, San Jose, CA) with a 0.22 pM 
filter.
The following primary polyclonal antibodies were used for immunochemical 
detection o f phase I and II proteins: goat anti-rat CYP1A1 (1:1000 dilution, Gentest), 
rabbit anti-rat CYP2B1 (1:1000 dilution, Research Diagnostics, Flanders, NJ), rabbit anti­
rainbow trout CYP3A iso-enzyme (1:1000 dilution, kindly donated by Dr. Malin 
Celander, University o f Goteborg, Goteborg, Sweden), rabbit anti-human CYP2E1 
(1:1000 dilution, Research Diagnostics), goat anti-rabbit EH (1:1000 dilution, Oxford 
Biomedical Research, Oxford, MI) and rabbit anti-human UDPGT1A1 (1:500 dilution, 
Gentest). The secondary antibodies were donkey anti-goat IgG (1:2500 dilution, Research 
Diagnostics) for CYP1A and EH and goat anti-rabbit IgG (1:3000 dilution, Bio-Rad 
Laboratories) for detection o f all other proteins. A pre-stained molecular weight standard
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was purchased from Bio-Rad Laboratories and a specific human UDPGT1A1 molecular 
weight standard was acquired from Gentest.
2.2.2 Sample collection
Liver tissues were obtained from five SL belugas stranded in the summers of 
2000 and 2001. The samples, identified as SL1, SL2, SL3, SL4 and SL5, were excised 
12-18 hours after discovery of the carcass and immediately stored in liquid nitrogen. A 
sixth individual, SL6 , was stranded alive in the summer o f 2003 and had to be 
euthanized; hepatic tissue was taken within 15 min after death and frozen on dry ice for 2 
d until it could be stored at -80  °C. Tissue degradation in these stranded SL animals is 
ranked by the extent o f autolysis, which was measured histologically (Table 2.1). 
Autolysis was minimal in SL6 and mild in SL4; however, all other SL samples were 
moderately to severely autolysed. Liver tissues from ten CA belugas were obtained 
during native subsistence hunting in August of 2002 (CA1, CA2, CA3, CA4, CAS) and 
2003 (CA6 , CA7, CA8 , CA9, CA10). All carcasses were sampled within 30-90 min of 
death, and liver samples were immediately transferred in the gas phase o f a liquid 
nitrogen dry shipper. After transport, all samples were frozen at -80  °C. Biological and 
physiological details on the SL and CA individuals are provided in Table 2.1.
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Table 2.1. Sample collection, biological and physiological data for beluga whale (A) 
from the St. Lawrence River Estuary (Quebec) and (B) from the Canadian Arctic 
(Nunavut).
A
Sample Sex Age Length Weight Extent of Date Location stranded
ID (yr) (cm) (kg) autolysis stranded
SL1 F 4.5 316.0 625.0 Extreme 07/26/00 Tadoussac
SL2 M 27 410.0 410.0 Extreme 07/29/01 lie au Caribou, Cote 
Nord
SL3 M 5.5 298.0 342.0 Moderate 09/28/01 lie Verte
SL4 F 3.5 300.0 334.5 Mild 1 0 /0 2 /0 1 Pointe-au-Pere
SL5 M 27.5 385.0 839.5 Marked 11/19/01 Baie du HaHa, Bic
SL6 F Neonate 144.0 41.5 None 07/31/03 Ste-Luce-sur-Mer








Date coUected Location collected
CA1 F Adult ND ND 08/11/02 Arviat, w. Hudson Bay
CA2 F Juvenile ND ND 08/11/02 Arviat, w. Hudson Bay
CA3 F Adult ND ND 08/12/02 Arviat, w. Hudson Bay
CA4 F Neonate ND ND 08/12/02 Arviat, w. Hudson Bay
CA5 F Adult ND ND 08/12/02 Arviat, w. Hudson Bay
CA6 F Adult ND ND 08/06/03 Arviat, w. Hudson Bay
CA7 F Adult ND ND 08/06/03 Arviat, w. Hudson Bay
CA8 M Adult ND ND 08/06/03 Arviat, w. Hudson Bay
CA9 M Juvenile ND ND 08/08/03 Arviat, w. Hudson Bay
CA10 M Adult ND ND 08/09/03 Arviat, w. Hudson Bay
^Estimated from skin colour (See Materials and Methods section).
ND = not determined.
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The age classification of the SL and CA belugas, regardless of precise age as in 
the case o f  the CA animals, was based on established practices. Based on data collected 
from two Arctic beluga populations, sexual maturity o f beluga to adults occurs at 
approximately 7 years o f age for females and 8  years of age for males as indicated by a 
transition o f  the skin colour from grey to white (Hobbs et al., 2003). Therefore, SL1, SL3 
and SL4 were juveniles and SL2 and SL5 were older adults. With the exception o f CA2 
and CA9 (juveniles) and CA4 (neonate), all the CA belugas were adults.
2.2.3 Preparation o f  hepatic microsomes
Microsomes were prepared by differential ultracentrifugation as described by 
Nilsen et al. (1998). Briefly, liver tissues were thawed on ice. Three volumes (liver 
weight per volume) of buffer (0.1 M K2 H P 04, 0.15 M KC1, 1 mM Na2EDTA, 1 mM 
DTT, 20% glycerol, pH 7.4) were added and the mixture was homogenized with an 
Ultra-Turrex. The homogenate was centrifuged at 12 500 g (20 min, 4 °C). The 
supernatant was centrifuged at 100 000 g (60 min, 4 °C). The pellet was resuspended in 
one volume o f buffer (0.1 M K2 HPO4 , 1 mM Na2EDTA, 1 mM DTT, 20% glycerol, pH 
7.4) and stored at -80  °C.
2.2.4 Microsomal protein and total cytochrome P450 content
Microsomal protein content was determined by the spectrophotometric method of 
Bradford (1976) using BSA as the standard (0.2 to 1.0 mg/ml). Absorbance was 
measured using a Dynatech Labs MRX UV/Vis microplate reader equipped with a 570 ±
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5 nm filter. Total CYP content was initially assessed by the dithionite-difference spectra 
of carbon monoxide-treated microsomes (Omura and Sato, 1964) using a Cary 300 Bio 
dual-beam UV-Vis spectrophotometer. However, a large peak at 420 nm suggested 
possible CYP degradation or hemoglobin and methemoglobin contamination. Treatment 
with ascorbic acid and phenazine methosulfate allowed for measurement o f cytochrome 
P450 content in the presence o f these contaminating proteins (Johannesen and DePierre, 
1978).
2.2.5 Catalytic assays
The 7-ethoxyresomfin-O-deethylase (EROD) activity was assessed using the 
fluorescence microplate assay o f Eggens and Galgani (1992). EROD activity in the 
beluga microsomes was measured under optimized assay conditions (e.g., pH 8.0 and 37 
°C) based on previously published procedures (White et al., 1994, 2000). Testosterone 
hydroxylase activity was determined as per the method of Li and Letcher (2002) based on 
grey seal hepatic microsomes including the use o f 6 a-hydroxytestosterone as internal 
standard, with a few exceptions. The buffer was set to pH 8.0 and the incubation mixtures 
were pre-incubated for 5 min at 37 °C. At time t = 0 min, one addition of NADPH 
regenerating system was added (50 pi solution A, 10 pi solution B). Testosterone 
metabolism was analyzed using a Waters 2695 Alliance HPLC system equipped with a 
Zorbax Eclipse XDB-C18 column (5 pm, 250 x 4.6 mm i.d.) and a Waters 2487 UV-Vis 
detector. Phase II glucuronidation was assessed using 1-naphthol as the substrate 
(Wolkers et a l, 1998). In a total reaction volume of 200 pi, 100 mM phosphate buffer
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(pH 8.0, 3 mM MgGh), 250 pM 1-naphthol, 1 mg/ml microsomes and Brij-58 (1 mg/ml) 
were pre-incubated for 5 min at 37 °C. The reaction was initiated by UDP-glucuronic 
acid (3 m M ) and was terminated by cold acetonitrile (200 pi) after 20 min. Mixtures were 
vortexed, left on ice for 30 min, then centrifuged (2000 rpm, 10 min). The supernatant 
was filtered through a 0.45 pm syringe filter and 5 pi was analyzed by HPLC using a 
Jasco FP-920 fluorescence detector (A,ex = 290 nm, 7,em -  330 nm). A 200 pM 1- 
naphthylglucuronide (1-NG) standard was prepared in methanol, and calibration curve 
standards were prepared by serial dilution. 1-NG was eluted with lOmM NaH2PC>4 (pH 
2.5, 17.5% acetonitrile) (Wortelboer et al., 1992). The flow rate was set to 2.0 ml/min for 
a total run time o f 20 min (retention time of 1-NG was 15.4 min).
2.2.6 Immunochemical analysis
Microsomal proteins (45 pg per well) were separated by SDS-polyacrylamide gel 
electrophoresis (Laemmli, 1970) and electroblotted from the gel onto a nitrocellulose 
membrane (Towbin et al., 1979). Proceeding application o f the primary antibody, an 
appropriate horseradish peroxidase (HRP)-labeled secondary antibody was incubated 
with the membranes, followed by an HRP-colour reagent (4-chloro-1 -napthol plus 
hydrogen peroxide solution) to visualize the cross-reactive bands. Molecular weights 
were approximated by comparison with a simultaneously run pre-stained molecular 
weight standard (5 pi in well).
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2.2.7 Data analysis
The precision of all assays was assessed by intraday (n > 3) replicate analysis for 
each individual beluga. It was not possible to assess the statistical significance o f the 
differences in specific catalytic activities for the CA and SL animals as a function o f sex 
or age because of the small number o f individual belugas, due to the inherent difficulty 
and cost in obtaining samples. In the case o f the SL animals, catalytic activities were 
generally not detectable. However, among adult CA animals it was possible to 
statistically assess the significance o f  the simple linear regression between pairings o f 
EROD, testosterone hydroxylase and UDPGT activities. All hypotheses tested were two- 
tailed and were based on a maximum probability o f a type-I error (a) that was set at 0.05 
(p < 0.05).
2.3 Results
2.3.1 Microsomal protein and total CYP content
Microsomal protein and total CYP contents of the beluga liver samples are given 
in Table 2.2. Dithionite difference spectra o f SL1 to SL5 showed a peak at 420 nm, but 
not at 450 nm, even when treated with ascorbic acid and phenazine methosulfate (PMS) 
to remove the interfering CO-hemoglobin peak at 420 nm. Spectra o f SL6  and the CA 
individuals showed a large 420 nm peak and no detectable 450 nm peak using the 
conditions of Omura and Sata (1964). However, when the SL6  and CA1 to CA10 
microsomes were treated with ascorbic acid and PMS, a clear P450 peak was revealed 
and detected (spectra not shown).
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Table 2.2. Microsomal protein content, CYP content and monooxygenase activity in the 
livers o f stranded St. Lawrence and captured Canadian Arctic beluga whale.
Sample ID Microsomal yield





SL1 2.9 ±0.1 ND ND
SL2 1 .6  ± 0 .1 ND ND
SL3 2.9 ± 0.4 ND ND
SL4 6.3 ± 0.2 ND 1 2  ± 1
SL5 3.1 ±0.4 ND ND
SL6 8.4 ± 0.3 170 87 ± 15
CA1 1 1 .0  ± 2 .0 180 107 ± 6
CA2 13.0 ± 1.0 140 51 ± 3
CA3 11.2 ±0.4 130 61 ± 2
CA4 16.0 ± 2 .0 130 107 ± 10
CA5 8.2 ± 0.5 60 33 ±2
CA6 7.7 ±0.1 170 99 ±5
CA7 6.7 ± 0.2 80 6 6  ± 10
CAS 8 .1  ± 0 .2 180 90± 13
CA9 6.3 ± 0.2 90 47± 10
CA10 5.5 ±0.1 240 260 ± 2 0
Values are means ± SD (n > 3 replicates).
* Replicate analyses were not possible due to limited available tissue (microsomes). 
ND = Not detectable.
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2.3.2 Phase I  and II  enzyme activities
Microsomal CYP1A activities, as measured by EROD activity, were not 
detectable for the SL1, SL2, SL3 and SL5 belugas, whereas activity in the SL4 animal 
was low but measurable (12 ± 1 pmol/mg/min). In contrast, the freshly sampled SL6 
neonate had a mean EROD activity o f 87 ± 15 pmol/mg/min. The average EROD rates 
in the hepatic microsomes of the CA individuals were 68 ±34 pmol/mg/min in the three 
juveniles, 73 ± 30 pmol/mg protein/min in the five adult females, and highest at 175 ± 85 
pmol/mg/min in the two adult males (Table 2.2).
Fig. 2.1 presents the measurable testosterone hydroxylase activities in the hepatic 
microsomes. The major hydroxytestosterone metabolite formed in all o f the CA 
microsomes, and in SL6, was 6 p-hydroxytestosterone. In SL6 , the mean rate o f 613- 
testosterone hydroxylase was 351 ± 4 2  pmol/mg/min, and was 343 ± 235, 613 ± 304, 450 
± 115 pmol/mg/min in the CA juveniles, females and males, respectively. The other 
minor metabolite detected in 9 o f the 10 CA assay samples was identified as 
androstenedione, whereas 2a-, 6 a-, 7a-, 15a-, 16a- and 16P-hydroxytestosterone 
metabolites were not detectable. No measurable hydroxytestosterone metabolite 
formation was found for SL1 to SL5. There was no significant correlation between the 
rates of 6 P-hydroxytestosterone formation {p < 0.05, r2  = 0.02, n = 10 samples) or 
androstenedione formation (p < 0.05, f  = 0.07, n = 9 samples) with CYP 1 A-mediated 
EROD activity in the CA animals. However, there was a significant positive correlation 
{p < 0.05, r2 = 0.35, n = 9) between the rates o f 6 p-hydroxytestosterone and 
androstenedione formation in the CA belugas.
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Fig. 2.1. Testosterone metabolism to 6 p-hydroxytestosterone (white bars, n = 3) and 
androstenedione (black bars, n = 3) in the hepatic microsomes of St. Lawrence River 
Estuary (SL) and Canadian Arctic (CA) beluga whales. Microsomes (1 mg/ml) were 
incubated with 250 pM testosterone at 37°C in phosphate buffer (lOOmM NaKLPCL, pH 
8.0, 3mM MgCL, ImM EDTA), and the reaction was initiated by the addition ofNADPH 
regenerating solution. Error bars represent the standard deviation.
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UDPGT activity in the beluga microsomes as measured by the rate o f 1-NG 
formations is given in Fig. 2.2. The formation rate of 1-NG was comparable for the CA 
juveniles, adult females and adult males, at values o f 1922 ± 1063, 3076 ± 1237 and 2791 
± 11 0 2  pmol/mg/min, respectively. For SL6, the 1-NG formation rate was 830 ± 244 
pmol/mg/min.
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Fig. 2.2. Formation o f 1 -naphthylglucuronide in the hepatic microsomes o f St. Lawrence 
River Estuary and Canadian Arctic beluga whales. Microsomes (1 mg/ml) were incubated 
with 250 pM 1 -naphthol and 1 mg/mg (protein) Brij-58 at 37°C in PBS (lOOmM, pH 8.0, 
3mM MgCfe). The reaction was initiated by the addition o f UDP-glucuronic acid (3 mM). 
Each bar is the mean o f n = 3 replicates, and error bars indicate the standard deviation.
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2.3.3 Immunodetection o f  phase I  and IIproteins
Western blotting of the microsomal fractions with the anti-rat CYP1A1 antibody 
revealed two distinct cross-reactive protein bands (around 50 and 53 kDa) in all the SL 
and CA samples comparable to the characteristic molecular weight range for CYP 
proteins (Fig. 2.3A). Using the CYP2B1 Ab, two weak bands at 48 and 55 kDa were seen 
for SL6 and the CA beluga (Fig. 2.3B). A band cross-reactive with anti-rainbow trout 
P450con (a putative CYP3A homologue) was visible at a molecular weight of 
approximately 52 kDa (Fig. 2.3C) in the SL and CA samples. Blotting with anti-CYP2E 
resulted in one distinct band for all samples at a molecular weight near 53 kDa (Fig. 
2.3D). Addition of anti-rabbit EH resulted in a strong band at around 52 kDa in the SL 
and CA belugas (Fig. 2.3E).
Detectable cross-reaction with anti-human UDPGT1A was seen for SL4, SL5 and 
SL6 (Fig. 2.3F). The mobility o f these approximately 50 kDa bands was comparable to 
that of a concurrently run human UDPGT1A molecular weight standard (about 56kDa, 
Fig. 2.3F). In SL1, SL5 and SL6 a cross-reactive band was seen at around 45 kDa. 
Further investigation is required to identify this protein, as the mobility is within the 
appropriate range o f a UDPGT protein. All ten o f the CA samples exhibited both o f the 
45 and 50 kDa bands.
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Fig. 2.3. Immunoblot of St. Lawrence River Estuary and Canadian Arctic beluga whale 
hepatic microsomes cross-reacted with (A) goat anti-rat CYP1A1 polyclonal antibody 
(PAb) at a 1:1000 dilution, (B) rabbit anti-rat CYP2B1 PAb at a 1:1000 dilution, (C) 
rabbit anti-rainbow trout CYP3A PAb at a 1:1000 dilution, (D) rabbit anti-human 
CYP2E1 PAb at a 1:1000 dilution, (E) goat anti-rabbit EH PAb at a 1:1000 dilution, (F) a 
rabbit anti-human UDPGT antibody at a 1:5Q0 dilution. An HRP-conjugated donkey anti­
goat secondary antibody at a 1:2500 dilution was used to visualize CYP1A- and EH-type 
protein bands. An HRP-conjugated goat anti-rabbit secondary antibody at a dilution of 
1:3000 was applied to visualize CYP2B-, CYP3A-, CYP2E and UDPGT-type bands. All 
sample wells were loaded with 45 pg o f beluga hepatic microsomal protein. The first lane 
was loaded with 5 pi o f molecular weight standard (Mw Std.). All membranes were 
scanned at the same resolution and exposure except for the CYP2B membranes, which 
were scanned at a higher exposure to ameliorate visualization o f faint cross-reactive 
CYP2B-type bands.
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Fig. 2.3
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Two general points regarding the blots should be noted. Firstly, the CA beluga 
protein bands were generally more intense (except in comparison to SL4 and SL6 ) and 
the intensities varied less between individuals than the band intensities of the SL 
individuals. Secondly, although putative P450 cross-reactive protein bands in the MW 
range for CYP proteins were detected in all CA lanes, often proteins in only a few of the 
SL samples exhibited cross-reactivity when incubated with the same antibodies under 
identical immunoblotting conditions. It should also be noted that samples for each of Fig. 
2.3(A-F) were not all run in the same gel (due to a limited number o f lanes in each gel) or 
in gels with the same lane width (i.e. 5 vs. 10 lanes). Therefore, membranes in the figure 
were scaled as closely as possible to the same size, and bands from each population were 
grouped together for clarity. It may thus appear that there are variations in band 
mobilities; however, the band mobilities were calculated using the molecular weight 
standard run with every gel (not all shown in Fig. 2.3) and showed no major differences 
when comparing the same bands run on different gels.
2.4 Discussion
Although biotransformation is often a major factor in the toxicokinetics and fate 
of organic contaminants, little is known regarding characterization and catalytic activity 
o f phase I and II xenobiotic-metabolizing enzymes in marine mammals. A greater 
understanding o f metabolic potential is particularly important in marine mammals that 
are exposed to high levels of contaminants, such as those living in the St. Lawrence River 
Estuary. In this study, antibodies against different phase I and II isozymes showed cross­
reactivity with homologous proteins in beluga liver microsomes. EROD, testosterone
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hydroxylase and UDPGT catalytic activities measured mainly in the CA animals were 
consistent with the immunologically characterized enzyme proteins. Our study reports for 
the first time in any cetacean species the catalytic and immunochemical detection of 
hepatic UDPGT and the immunochemical detection of a hepatic EH protein. Despite the 
specificity o f the different antibodies toward the respective proteins, there were 
artifactual and non-specific cross-reactivities o f some antibodies due to the less specific 
nature o f polyclonal antibodies (Luzio and Jackson, 1998).
2.4.1 CYP1A
The expression of CYP1A is highly inducible across taxa, including marine 
mammals, via an aryl hydrocarbon receptor-mediated mechanism as a consequence o f 
exposure to AhR-active substrates such as polychlorinated dibenzo-p-dioxins (PCDDs) 
and dibenzofurans (PCDFs) and other planar, dioxin-like contaminants (e.g., 
benzo[a]pyrene and non-ortAo-chlorinated PCBs). Beluga whales from SL and Arctic 
populations are exposed to contrasting levels and patterns o f AhR agonists (Metcalfe et 
a l, 1999). However, an immunologic comparison o f CYP1A in individual belugas from 
SL and a CA population has not been reported. Previously, the only published study on 
hepatic CYP enzymes in beluga whale, from the MacKenzie River Delta (White et al.,
1994), revealed the presence of one CYP1A band at 53 kDa using a monoclonal anti-scup 
antibody and a polyclonal anti-mouse antibody that is cross-reactive with CYP1A1 and 
1A2 in mice and rats. Using the anti-rat antibody, which recognizes both rat CYP1A1 and 
1A2, two distinct bands were detected in both the SL and CA (Arviat, western Hudson 
Bay) samples. We postulate that the 53 kDa band is a CYP1A1 homologue based on
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electrophoretic migration (White et a l ,  1994). The 50 kDa band may suggest the 
presence o f a CYP1A2 homologue, according to previous studies o f CYP1A1 and 1A2 
type proteins in other marine mammals using polyclonal anti-CYPlAl antibodies. In 
1998, Goksoyr et al. using an anti-cod CYP1A1, reported two bands at 54 and 51-52 kDa 
in minke whales which were thought to be CYP1A1 and CYP1A2-Iike. Bandiera et al. 
(1995) reported the cross-reactivity o f a polyclonal anti-rat CYP1A1 antibody with two 
separate proteins in polar bear microsomes, which the authors suggested were CYP1A1 
and CYP1A2. The anti-rat CYP1A1 we used cross-reacts with rat CYP1A1 (52 kDa) and 
1A2 (50 kDa). White et al. (1994) had previously suggested that expression of CYP1A2 
may have been too low to detect or that the enzyme did not exist in the individual beluga 
(i.e., from the population in the MacKenzie River Estuary) that were examined. A further 
explanation may be that the affinity o f the anti-mouse antibody for the CYP1A2 protein 
in the liver o f the MacKenzie River beluga was less than that of the anti-rat antibody used 
in the present study. The presence o f a beluga protein similar to rat CYP1A2, 
nonetheless, can only be suggested by our data and indicates the need for further 
investigation.
We measured similar EROD activity levels in the CA belugas as was reported in 
the MacKenzie River beluga collected in 1989 (White et al., 1994). Histological 
examination revealed that SL4 was the least autolyzed of the dead stranded SL beluga. 
Although the EROD activity was low, the Ab cross-reactivity o f CYP1A proteins in SL4 
was most intense of all the animals under study, despite the apparently poorer tissue 
preservation relative to the CA animals. This suggests that if  appropriately preserved 
adult liver tissue could be obtained, higher expression o f CYP1A protein would be
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observed, consistent with higher levels o f AhR agonist exposure in SL beluga than in the 
CA belugas.
2.4.2 CYP2B
Isozymes o f the CYP2, CYP3 and CYP4 subfamilies are also inducible in 
mammals (Lewis and Lake, 1997; Lewis, 2000). In polar bear, the expression o f CYP2B1 
cross-reactive protein was highly correlated with levels o f ortho-chlorine substituted 
PCBs and chlordane pesticides (Bandiera et al., 1995; Letcher et al., 1996). However, 
immunochemical assessment o f the expression o f CYPs other than CYP1A is rare in 
cetaceans, and comparisons among individuals from different populations are not known 
(White et al., 1994, 2000; Boon et al., 2001). CYP2B substrates are usually nonplanar, 
lipophilic compounds (Lewis et al., 1998). It has been postulated that marine mammals 
are basically deficient in CYP2B-associated proteins (Goksoyr, 1995). Until recently, 
there has been little immunochemical evidence of CYP2B proteins in cetaceans. For 
example, White et al. (1994) did not detect bands using polyclonal and monoclonal anti­
rat antibodies against CYP2B, nor with a putative anti-scup CYP2B antibody. Cross­
reactive bands were, however, visible using anti-rabbit CYP2B4 and anti-dog CYP2B11 
polyclonal antibodies. Little to no CYP2B-like protein expression has been reported for 
other cetacean species from any location. Goksoyr (1995) found low cross-reactivity in 
minke whale using the Amersham ECL CYP2B1/2 kit. Boon et al. (2001) did not detect a 
cross-reactive protein with a monoclonal anti-rat CYP2B1/2 in the liver o f sperm whale 
(Physeter macrocephalus). The polyclonal anti-rat CYP2B1 antibody used in the present 
study specifically recognizes rat CYP2B1 and CYP2B2. Two weakly cross-reactive
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bands were observed in SL6  and in CA1-10. We conclude from the electrophoretic 
migration that the two bands represent CYP2B-type proteins.
In this study, major metabolites associated with CYP2B activity in mammals, 
16a- and 16P-hydroxytestosterone (Arlotto et al., 1991), were not detected in any of the 
beluga samples using the testosterone hydroxylase assay. However, androstenedione 
formation was measurable in the CA animals, and is also known to be catalyzed in part 
by CYP2B1 in rats (Arlotto et al., 1991). It is also possible that for beluga whale in 
general, testosterone is a poorer substrate for CYP2B-like enzymes. Evidence supporting 
the existence o f CYP2B-type catalytic activity in SL and CA beluga whales comes from 
the fact that animals from both populations are capable o f metabolizing ortho-chlorine 
substituted PCBs, known to be CYP2B1 substrates in rodents (McFarland and Clarke, 
1989), leading to the formation o f methylsulfonyl- (MeSC>2-) PCBs (Letcher et al., 
2000b). However, it is difficult to conclude that MeSCVPCB and MeSCh-DDE formation 
is contingent only on CYP2B-like mediation of precursor PCB metabolism. In seals for 
example, other CYP isozymes (e.g. CYP3A) are involved in the PCB arene oxide 
formation from ortho-chlorine substituted PCB congeners (Li et al., 2003).
2.4.3 CYP3A
CYP3A is a constitutive P450 that metabolizes steroid hormones, but it is also 
associated with the biotransformation o f xenobiotics such as the chlorobomanes and 
PCBs in seals (van Hezik et ah, 2001; Li et al., 2003). Immunoblots with anti-P450con 
identified a single CYP3A-like protein in SL and CA beluga liver microsomes. Recently, 
Celander et al. (2000) confirmed the presence (particularly in liver) o f CYP3A-like
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enzymes in various tissues of four pilot whales by immunochemical methods. 
Testosterone hydroxylase activities and Western blotting have also implicated the 
existence o f CYP3A-like enzymes in minke whale (Goksoyr et al., 1988, 1989). The 
molecular weight o f the CYP3A-type protein found in our beluga study, 52 kDa, 
compares favourably with the immunological results for other cetacean species. 60- 
Hydroxytestosterone formation is a marker o f CYP3A activity in mammals, and in all CA 
and SL6  microsomes the major conversion of testosterone was to 60- 
hydroxytestosterone. A significant correlation between 60-hydroxytestosterone and 
androstenedione formation would suggest that CYP3A mediates, at least in part, the 
formation of androstenedione in beluga whales.
2.4.4 CYP2E
CYP2E enzymes metabolize substrates o f relatively low molecular weight and 
diverse structure (Lewis et al., 1998) and are associated with xenobiotic metabolism 
(Peter et al., 1990). The rabbit anti-human CYP2E1 antibody used in this study is reactive 
towards CYP2E1 in humans and CYP2E proteins in rat, rabbit and hamster hepatic 
microsomal fractions. A hepatic CYP2E-like protein detected in the SL and CA animals 
is in agreement with the previous immunochemical findings in the liver o f MacKenzie 
River delta beluga (White et al., 1994).
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2.4.5 Epoxide hydrolase
Currently, no literature has been published on the existence of EH in either 
cetaceans or pinnipeds, although Bandiera et al. (1995) immunochemically characterized 
this enzyme in polar bear, which is at the top o f the Arctic marine food web. EH is an 
important enzyme in the formation o f hydroxylated (HO) metabolites of halogenated 
aromatic contaminants such as PCBs (Letcher et al., 2000a). HO-PCBs and HO- 
polybrominated diphenyl ethers (PBDEs) are generally thought to be formed via CYP- 
mediated formation o f arene epoxide intermediates or possibly via direct aromatic 
hydroxylation o f PCB and PBDE congeners (Letcher et al., 2000a; Hakk and Letcher, 
2003). The only known report of HO-PCBs and HO-PBDEs in a cetacean species was in 
the blood of killer whale (Orcinus orca) fed a diet o f wild Pacific herring (Clupea 
pallasi) (Bennett et al., 2004). Although a constitutive enzyme, EH exhibits moderate 
induction by certain anthropogenic compounds, such as Arochlor 1254 in humans 
(Hassett et al., 1998). The presence o f an EH protein similar to that found in rabbit is 
indicated by the immunoblots o f all SL and CA beluga samples. To our knowledge this is 
the only study on EH in marine mammals other than polar bear (Bandiera et al., 1995); 
the importance o f EHs in xenobiotic metabolism calls for further investigation o f these 
enzymes.
2.4.6 UDP-Glucuronosyltransferase
Limited knowledge exists regarding phase II enzymes in belugas and in marine 
mammals in general. MeSCVPCB and -D D E metabolites found in the adipose tissue of 
SL and western Hudson Bay beluga is chemical marker evidence o f phase II glutathione
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conjugation with meta-para arene oxide intermediates formed via CYP enzyme- 
mediation from precursor PCBs (Letcher et a l , 2000b). Goksoyr et al. (1988) found 
UDPGT catalytic activities o f 640 and 55.4 pmol/mg/min towards 4-nitrophenol and 
testosterone metabolism, respectively, in minke whale. Wolkers et al. (1998) 
characterized UDPGT activity in ringed seal (Phoca hispida) hepatic microsomes by 
measuring the glucuronidation activity towards 1-naphthol metabolism. We found very 
similar 1 -naphthylglucuronide formation rates in the CA belugas. The UDPGT activity of 
the neonate, SL6 , was within the range of activities found in the juvenile CA belugas. 
Western blotting showed a UDPGT-type protein in three o f  the SL belugas and all o f the 
CA belugas we studied, with electrophoretic migrations comparable to that o f a human 
molecular weight standard. The molecular weights of UDPGT in the samples and the 
standard are not expected to be identical due to potential differences in glycosylation o f 
the proteins (Gentest).
A number o f variables, such as enzyme induction or suppression, nutritional and 
reproductive status, age, sex and genetic variation, may account for differences in protein 
expression and catalytic activity (and thus, contaminant biotransformation capacity) 
among individual belugas and populations. Another factor may be sample preservation, 
especially in marine mammal research where it is very difficult to obtain fresh tissues 
from stranded individuals (Moore and Stegeman, 1996). Given the ~500 km coastline of 
the SL estuary where standings o f endangered beluga generally occur, and the large 
distances carcasses must be transported before invasive sampling can be performed, it is 
extremely rare that enzymatically viable tissues can be obtained. From a sampling 
perspective, we were thus fortunate to come across SL6 , which was found stranded alive,
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and also to obtain fresh CA tissues. For SL1 to SL5, questionable tissue preservation 
compromised the immunochemical and catalytic integrity of the phase I and II enzymes 
in these belugas. Loss of the heme group (as indicated by the absence o f total P450) and 
loss o f binding site integrity may partially explain the loss of catalytic activity. Generally 
less intense bands than those of the CA samples (or undetectable bands in the case of 
CYP2B) in the immunochemical analysis likely reflects loss of epitopic integrity, 
resulting in less cross-reactivity with the chosen antibodies. Preliminary examination 
(based on tissue firmness, i.e. less firm and more “pudding-like” in appearance suggested 
more degradation) of the SL1 to five 5 livers did not indicate comparatively better 
preservation o f SL4 hepatic tissues, which showed generally darker immunoblot bands 
and measurable EROD activity. However, SL4 microsomes were an orange-yellow 
colour comparable to the SL6  and CA microsomes, whereas microsomes from the other 
SL samples were dark green. Additionally, histopathological examination indicated that 
SL4 hepatic tissues were much less autolysed than tissues from the other dead stranded 
SL belugas. Despite the tissue degradation, immunochemical analysis still proved useful, 
regarding qualitative information on phase I and II proteins present in SL1 to SL5.
The acquisition of tissue in the form of skin/blubber biopsies from free-ranging 
live SL belugas may be a non-lethal alternative to the use o f extracted tissues from SL 
beluga carcasses (Hobbs et al., 2003) for measuring physiological, biochemical, genetic 
and expression differences between the SL and other beluga populations. Gauthier et al. 
(1999) recently reported the successful culturing o f skin fibroblasts from Arctic beluga 
whale, which are likely to have retained enzymatically viable CYP enzymes. CYP 
activity has also been measured in skin biopsies of other marine mammals (Stenella
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coeruleoabla, Balaenoptera physalus) (Fossi et al., 1999). However, MFO activity was 
only assessed through EROD, PROD, BROD and AHH assays, all o f which are mediated 
mainly by CYP1A in marine mammals (Watanabe et al., 1989; Letcher et al., 1996; 
Addison et al., 1998). It remains to be demonstrated whether other xenobiotic- 
metabolizing enzyme activities in beluga skin or other nondestructively sampled tissues 
would be a useful alternative to liver in studies o f metabolic potential. Here, we have 
been able to report the presence o f phase I and UDPGT enzymes in the main organ 
involved in detoxification/biotransformation, the liver. These results provide the rationale 
for future investigation into the presence o f these enzymes in alternate, nondestructively 
sampled tissues, and thus for the use o f such tissues in biotransformation and biomarker 
studies in beluga whales.
2.5 Conclusions
We report on the detailed immunochemical and catalytic profiling o f the enzymes 
mediating xenobiotic-metabolism in beluga whales from more than one distinct 
population. Immunochemical results indicated that profiles o f several major CYP 
enzymes, EH and UDPGT are similar between animals from the two populations, and for 
certain enzymes are comparable with previous hepatic enzyme characterization in beluga 
and other odontocete species. For the first time, proteins homologous to CYP3A, EH and 
UDPGT were identified in beluga whales. Hydroxytestosterone and 1- 
naphtholglucuronide formation in adequately preserved tissues from individuals from 
both populations indicate the presence o f CYP3A-type and UDPGT activities, 
respectively, in addition to CYP1A catalytic activity. Although questionable preservation
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of most o f  the SL samples lead to virtually undetectable catalytic activity, 
immunochemical protein profiling was still possible. We have shown that CA beluga 
have the potential to act as models for contaminant biotransformation studies on SL 
beluga, which will help to explain the potential impact o f specific organic pollutants on 
the endangered SL population, or in contaminant-exposed animals from other 
populations. Freshly sampled CA hepatic tissues are currently being used as a model in 
vitro metabolism system to assess biotransformation of organohalogen contaminants in 
beluga whales.
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CHAPTER 3
Organohalogen Contaminants and Metabolites in the Livers of Beluga 
Whales {Delphinapterus leucas) from the St. Lawrence River Estuary 
and western Hudson Bay, Canada1"
3.1 Introduction
Beluga whales {Delphinapterus leucas) live for 3 to 4 decades, feed high in the 
food chain and store large amounts o f fat as blubber. Akin to other marine mammals, 
belugas are consequently vulnerable to accumulation and potential effects o f lipophilic 
contaminants including established classes (PCBs and other organochlorines) and those 
o f emerging concern (polybrominated diphenyl ethers, PBDEs) (Norstrom and Muir, 
1994; Hites, 2004). In Canada, there are several populations o f beluga whales inhabiting 
Arctic regions and one isolated, threatened (COSEWIC, 2004) and highly contaminated 
(e.g. Muir et al., 1996a) population inhabiting the estuary o f the St. Lawrence River. High 
occurrences o f neoplasms, immunological and reproductive dysfunction in St. Lawrence 
beluga whales (SLB) have been linked to organochlorine exposures (De Guise et al.,
1995). Adipose concentrations o f PBDEs, used commercially as flame retardant additives
^M.A. McKinney, A. Arukwe, D. Martineau, P. Beland, S. De Guise, R.J. Letcher. In preparation.
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to polymers, are also reportedly much higher in SLB than in Arctic beluga whales (CAB) 
(Law et al., 2003). Despite the still lower levels of PBDEs cf. PCBs in both SLB and 
CAB (Stem and Ikonomou, 2000a,b, 2001; Lebeuf et al., 2004), temporal studies have 
demonstrated that PBDE concentrations in both populations remain on the rise (Law et 
al., 2003; Lebeuf et al., 2004), whereas PCB and OC levels appear to be not significantly 
changed or decreasing (Muir et al., 1996b).
In contrast to recent and continued use o f PBDEs, PCBs have been banned since 
1977 in both Canada and the USA since they are persistent, bioaccumulative and toxic 
(PBT) substances in the environment (Lipnick and Muir, 2001). PCBs have been 
associated with reproductive impairment and endocrine- and immune-related toxicities in 
cetaceans (Colbom and Smolen, 1996). Recent studies have demonstrated that PBDEs 
elicit some similar effects in experimental animals, such as reproductive and liver 
dysfunction as well as thyroid-associated developmental neurotoxicity (Damerud, 2003).
Although congeners of both PCBs and PBDEs are considered persistent organic 
pollutants, their biological recalcitrance and toxicities depend on congener structure. 
Metabolic capacity is species- and population-specific, being influenced by a variety of 
physiological factors as well as by exposure to enzyme-inducing contaminants (Boobis et 
al., 1990; Smith, 1991; Nyman et al., 2003). Biotransformation o f organic contaminants 
is mediated mainly in the liver by the phase I cytochromes P450 (CYP) that convert 
xenobiotics to less lipophilic, and potentially to more reactive forms. Metabolites formed 
from aromatic organohalogens are subject to further metabolism via phase II conjugative 
enzymes, such as glutathione-S-transferases (GSTs) and UDP-glucuronosyl transferases 
(UDPGTs).
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For marine mammals (e.g., seals and whales), a classification scheme has been 
proposed and applied to assess the capacity for CYP-mediated oxidative metabolism of 
PCBs based on congener structures and residual congener-specific concentrations found 
in tissue (Boon et al., 1992, 1997; Li et al., 2003). Although structurally related, the 
potential metabolic pathways of PBDEs in marine mammals remain unknown. Meerts et 
al. (2000) found that CYP2B, and to a lesser extent CYP1A and CYP4A3, were involved 
in the metabolism of some PBDE congeners in laboratory rats.
A more definitive and direct way o f assessing metabolic capacity towards PCBs 
and PBDEs is by the determination of tissue metabolite residues (Letcher et al., 2000a). 
Hydroxylated- (HO-) PCBs have been identified as important classes of PCB metabolites 
in biota, and found mainly in blood. HO-PCBs form via CYP-mediated, direct insertion 
o f the HO-group on a precursor PCB congener, or via CYP-mediated arene epoxide 
formation, followed by either enzyme-mediated or spontaneous epoxide opening. Blood 
retention occurs due to competition with thyroxine (T4) for binding to thyroid hormone 
transport proteins (e.g., transthyretin (TTR)). HO-PCBs and other chlorinated phenolic 
contaminants (e.g. pentachlorophenol (PCP) and 4-HO-heptachlorostyrene) have been 
reported in the plasma o f humans, fish, birds, and mammals (e.g. Asplund et al., 1999; 
Meironyte-Guvenius et al., 2002; Campbell et ah, 2003; Hoekstra et al., 2003; Li et ah, 
2003; Sandala et al., 2004). Methylsulfonyl- (MeS0 2 -) PCB metabolites are formed via 
arene epoxide intermediates, and have been shown to be PBT substances in mainly 
marine mammals and humans (e.g. Haraguchi et al., 1989; Troisi et ah, 1998; Karlson et 
al., 2000; Letcher et ah, 2000b; Meironyte-Guvenius et ah, 2002; Chu et ah, 2003; 
Hoekstra et ah, 2003).
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Although less is known concerning PBDE metabolism (Bakk and Letcher, 2003), 
particularly in wildlife, HO-PBDEs have been reported in fish (Asplund et al., 1999; 
Letcher et al., 2003) and also in killer whale (Bennett et al., 2004). Hydroxylated PBDE 
metabolites were detected in laboratory rodents dosed with BDE47 (6 m  and Klasson- 
Wehler, 1998), BDE99 (Hakk et al., 1999), BDE100 (Hakk et al., 2004) and BDE209 
(Morck et al., 2003). Stapleton et al. (2004a,b) demonstrated that BDEs 99, 183 and 209 
were debrominated to lower brominated congeners in the intestine of common carp 
(Cyprinus carpio), indicating that debromination is also a metabolic pathway for PBDEs. 
PBDE congener patterns in wildlife also suggest environmental or metabolic 
debromination pathways (Ikonomou et al., 2002). To our knowledge, HO-PCBs, HO- 
PBDEs or other HPCs have not been reported in liver tissues o f any wildlife species.
In this study, HO-PCB and HO-PBDE metabolites in addition to PBDEs, PCBs, 
MeS0 2 -PCBs and OC pesticides are identified, quantitatively determined and compared 
in liver tissues from SLB and CAB. We also test the hypothesis that SLB have higher 
liver concentrations o f enzyme-inducing contaminants and metabolites than CAB.
3.2 M aterials and Methods
3.2.1 Chemicals and standards
PCB and OC standards were supplied by the Canadian Wildlife Service (Ottawa, 
ON, Canada). Standards for PBDE, MeO-PCB, MeO-PBDE and MeS0 2 -PCB analyses 
were provided by Dr. Ake Bergman (Stockholm University, Sweden), with the exception 
o f BDE-28 and -49, which were purchased from Wellington Laboratories (Guelph, ON, 
Canada). The internal standards used were as follows: CB83 and CB122 for PCBs and
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OCs, BDE-30 for PBDEs, 4-HO-CB72 (4-HO-2,3 \5 ,5  Metrachlorobiphenyl) for HO- 
PCBs, 2 ’-HO-BDE28 (2’-OH-2,4,4’-tribromodiphenyl ether) for HO-PBDEs and 3- 
CH3SO2-2 -CH3 -2  ’ ,3 ’ ,4 ’, 5,5 ’ -pentachlorobiphenyl (M eS02-PCB-IS) for M eS02-PCBs. 
PCBs are numbered using the notation o f Ballschmiter and Zell (BZ, 1980). PBDEs are 
numbered according to the corresponding BZ notation for PCBs. PCB and PBDE 
metabolites are numbered keeping the same BZ notation and adding the position o f the 
HO- and/or M eS02- group as a prefix to the name (Maervoet et al., 2004).
The chromatographic supports used were: Florisil® deactivated with 1.2% H20  
(Fisher Scientific, Ottawa, Ontario, Canada), basic alumina deactivated with 2.3% H20  
(Fisher Scientific) and silica acidified with 22% H2S0 4  (Milwaukee, WI, USA). All 
solvents and other reagents were o f at least analytical grade quality.
3.2.2 Liver sampling
Details o f the beluga whales and tissue sampling are described in McKinney et al. 
(2004). In brief, the liver tissues of five dead, stranded SL belugas in 2000 and 2001 were 
sampled 12-18 hours after stranding were reported and stored in liquid nitrogen. There 
were two adult males and three juveniles. In 2003, the liver tissues o f a sixth SL beluga 
(neonate), which was stranded alive, were sampled less than 15 min post-mortem. The 
CA beluga (n = 11) liver tissues were taken within 30-90 min o f death from individuals 
sacrificed as part o f native subsistence hunts in 2002 and 2003 near Arviat, Nunavut on 
the western shore of Hudson Bay. The CA animals were two adult males, six adult 
females and three immature belugas. Age classification was based on the colour change
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from grey to white at sexual maturity. The tissues were put into long-term storage at -20 
°C until chemical analysis.
3.2.3 Organohalogen and metabolite extraction
Extraction o f neutral, phenolic and methylsulfone organohalogens from beluga 
whale liver tissue was based on methods described elsewhere for blood, serum or plasma 
with modifications (Letcher et al., 1995, 2000b; Hovander et al., 2000; Sandau et al., 
2000a,b; Hoekstra et al., 2003; Li et al., 2003; Sandala et al., 2004). Briefly, 0.5 to 2.0 g 
of liver was ground with five equivalents o f sodium sulfate until homogenous. All 
analytes were then extracted from the sample by column chromatography with 60 ml of 
1:1 DCM:hexanes. The lipid content was quantified gravimetrically.
Phenolic analytes were isolated from the tissue, deprotonated and extracted into 
an aqueous phase o f 1 M KOH (in 1:1 EtOH: H2O). Deprotonated phenolics were re- 
protonated by the addition o f concentrated H2SO4, back extracted with 1:1 
MtBE:hexanes, and derivatized to their methoxylated analogues (MeO-PCBs, MeO-PCP, 
4-MeO-HpCS and MeO-PBDEs) by treatment with diazomethane. The MeO-derivative 
fraction (F5) was then concentrated and eluted through 3 g o f acid silica with 50 ml o f 
15:85 DCM:hexanes.
The organic phase from the original extract (after 1 alcoholic KOH treatment) 
contained all neutral analytes. After concentrating this fraction, analytes were separated 
on a column o f 8  g o f Florisil® in sequential fractions as follows: 38 ml o f hexanes to 
elute PCBs and PBDEs (FI), 34 ml o f 15:85 DCM:hexane to elute OC pesticides (F2), 54 
ml 1:1 DCM:hexanes to elute heptachlor epoxide and dieldrin (F3), and 90 ml of 7%
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MeOH in DCM to elute MeSOa-PCBs (F4). F4 was subjected to further clean up on a 
basic alumina column (3 g) eluted with 50 ml 1:1 DCM:hexanes (the first 10 ml were 
discarded).
3.2.4 Quantification o f  contaminants and metabolites
PCBs and OCs were separated and determined on a fused silica DB-5 column 
((5% phenyl)methylpolysiloxane, 30 m x 250 pm i.d., 0.25 pm film thickness, J&W 
Scientific Inc., Folsom, CA) in an Agilent 6890 GC system (Palo Alto, CA) equipped 
with a 63Ni pECD detector. An Agilent 7683 Series automatic liquid sampler and injector 
were used. The carrier gas was helium and the makeup gas was 5% CH4 in argon. Data 
were collected with HP Chemstation software. The GC ramping program was as follows: 
the oven temperature was held at 90°C for the Imin, increased to 200 °C at 15 °C/min 
and held for 2 min, then increased further to 280 °C at 2.5 °C/min and held for 9 min for 
a total run time o f 51.5 min. After PCB and OC determination in FI, F2 and F3, the three 
fractions were subsequently combined for GC-MS determination o f PBDEs. PBDEs, 
MeO-PCBs, MeO-PBDEs and MeSG2-PCBs were determined on an Agilent 6890N GC 
system with an Agilent 5973N MSD in the electron capture, negative ionization (ECNI) 
mode using selected ion monitoring (SIM). An Agilent 7683 Series injector and 
autosampler were used as per the GC-pECD. Helium was used as the carrier gas, and 
methane was used as the reagent gas. The GC ramping program for PBDE (F1/F2/F3) 
and MeO-PBDE (F5) containing fraction was as follows: temperature held at 80 °C for 2 
min, increased to 290 °C at 10 °C/min and held for 15 min, for a total run time o f 38 min.
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MS-ECNI(SIM) was set up for isotopic Br anions, i.e., m/z 79 and 81 amu (Sellstrom, 
1999; Athanasiadou, 2003). For MeO-PCBs and other chlorinated MeO-HPCs (F5), the 
initial oven temperature was 80 °C for 1 min, followed by an increase in the rate to 10 
°C/min to 250 °C and held for 5 min, then increased again by 5 °C/min to 300 °C and 
held for a further 5 min. The total run time was 38 min. SIM monitoring o f MeO-PCBs 
and MeO-HPCs was for [M]', [M+2]' and [M-15]' (M-CH3). Specifically, the ions 
monitored were: m/z 322 and 324 for 4-MeO-HpCS, m/z 322, 324 and 307 for MeO-tetra- 
CBs, m/z 356, 358 and 341 for MeO-penta-CBs, m/z 390, 392, 375 for MeO-hexa-CBs 
and m/z 424, 426 and 410 for MeO-hepta-CBs. Finally, for GC-MS(ECNI)(SIM) 
determination o f M eS02-PCBs (F4), the GC oven program initially held the temperature 
at 100 °C for 3 min, increased to 220 °C at 20 °C/min and held for 1 min, followed by an 
increase to 280 °C at 3 °C/min and held for 8  min. The total run time was 38 min. 
M eS02-PCB ions monitored were [M]' and [M+2)‘ for tetra-, penta-, hexa-, and hepta- 
chloro M eS02-PCBs. All injections were made in the splitless mode using an injection 
volume o f 1 pi.
All analytes under study were identified by comparison of GC retention and 
(where applicable) ECNI mass spectra to authentic standards. E-PCB is comprised o f the 
following 47 congeners, in order o f elution (if detected): PCB 31/28, 52, 49, 44, 42, 64, 
74, 70, 66/95, 60, 101, 99, 97, 110, 151, 149, 118, 146, 153, 105, 141, 179, 138, 158, 
129/178, 182/187, 183, 128, 174, 177, 156/171/202, 200, 172, 180, 170/190, 201, 203, 
195, 194 and 206. X-DDT consists o fp ,p ’-DDT, /?,/>’ -DDD and p ,p ’-DDD. E-HCH is the 
sum o f a-, P- and y-hexachlorocyclohexane. E-Chlordane (E-CHL) is the sum of
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oxychlordane, trans-chlordane, czs-chlordane, trans-nonachlor, cis-nonachlor and 
heptachlor epoxide. Z-Mirex is the sum of Mirex and photo-Mirex. Hexachlorobenzene 
(HCB), octachlorostyrene (OCS) and dieldrin were also analyzed for in the OC fractions. 
The average recovery for PCBs/OCs was 99 ± 9%, and thus recovery correction was not 
necessary. PCBs and OCs were then quantified by an external standard method. The 
PCB/OC method detection limit was 0.5 ng/g lipid weight.
For all o f the subsequent organohalogen classes, an internal standard approach 
was used for quantification. E-PBDE is the sum of the following 9 congeners, in order o f 
elution (if detected): PBDE 28, 49, 47, 100, 99, 154, 153, 138 and 183.1-HO-PCB is the 
sum of the quantification o f 13 congeners, if  detected, as MeO-PCB analogues: 4’-HO- 
CB104, 4 ’-HO-CB121, 3’-HO-CB85, 4 ’-CB120, 4-HO-CB112, 4-HO-CB107, 4-HO- 
CB165, 3’-HO-CB138, 4 ’-HO-CB130, 4-HO-CB187, 4’-HO-CB159, 3 ’-HO-CB180, 4- 
HO-CB193. Depending on detectability in the sample, some as yet unidentified penta-, 
hexa- and hepta-chloro HO-PCBs were also included, namely four HO-Cls-CBs, four 
HO-Cl6-CBs and one HO-CI7-CB. Although these congeners could not be definitively 
identified by comparison to previous HO-PCB determinations in other animals (Li et al, 
2003; Sandala et al, 2004; Sandau et al, 2000a,b), they were still quantified using the 
relative response factors of standards in their appropriate chlorinated isomer groups. 
Fourteen HO-PBDE congeners were analyzed for (as MeO-PBDE analogues): 6 ’-HO- 
BDE17, 4’-HO-BDE17, 6’-HO-BDE49, 2 ’-HO-BDE68, 6-HO-BDE47, 3-HO-BDE47, 5- 
HO-BDE47, 4 ’-HO-BDE49, 4-HO-BDE42, 6-HO-BDE90, 6-HO-BDE99, 2-HO- 
BDE123, 6-HO-BDE85 and 6-HO-BDE137. The E-M eS02-PCBs is thus the sum o f the
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aforementioned congeners and the following sixteen congeners in the mixed standard: 3- 
M eS02-CB52, 2-M eS02-CB49, 4-M eS02-CB52, 4-M eS02-CB49, 4-M eS02-CB64, 3- 
MeSO2-CB70, 3-MeSO2-CB101, 4-MeSO2-CB70, 4-MeSO2-CB101, 3-MeSO2-CB110,
3-M eS02-CB149, 4-MeSO2-CB110, 4-MeSG2-CB87, 3-MeSOr CB132, 4-M eS02- 
CB132, and 4-M eS02-CB174. For six M eS02-PCB congeners, standards were not 
available (3-M eS02-CB64, 3-M eS02-CB91, 4-M eS02-CB91, 3-M eS02-CB87, 3- 
M eS02-CB149, 3-M eS02-CB141, 4-M eS02-CB141). Their identities were confirmed by 
comparison to M eS02-PCB patterns from previous studies employing GC-MS(ECNI) 
analysis (Letcher et al., 2000b), and the relative response factors o f standards in their 
appropriate chlorinated isomer groups were used to quantify these analytes. Mean 
recoveries were 84 ± 11%, 76 ± 16%, 61 ± 13% and 141 ± 12 for PBDEs, MeO-PCBs, 
MeO-PBDEs and M eS02-PCBs, respectively. The high sulfone recoveries may be due to 
matrix effects (residual lipids in the samples) on the fragmentation patterns by ECNI 
because re-analysis by GC-pECD gave more consistent recoveries of 6 8  ± 3%. The 
method limits o f quantification for these compound classes were all approximately 0.5 
ng/g lipid weight (S/N = 10).
3.2.5 Quality control
The precision of the method was confirmed by intra-day duplicate analysis of 
three individual liver samples. For PCBs, PBDEs and M eS02-PCBs, the internal standard 
concentrations were within 8 %, 8 % and 10%, respectively, between duplicates. The intra­
day repeatability for HO-PCBs and HO-PBDEs was higher; however, using the internal 
standard method o f quantification, the variability in the congeners actually detected in the
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duplicated analyses was within 15%. With each batch of five beluga whale liver tissues 
analyzed, a method blank (n -  4) was also run. Where necessary (e.g. for BDE47), areas 
were blank subtracted.
3.2.6 Data analysis
All statistical analyses o f variance in contaminant concentrations in liver of 
beluga from the two populations was carried out using STATISTICA (version 6.0, 
StatSoft, 2003) or Excel (Microsoft, 1997). All hypotheses tested for analysis o f variance 
in analyte concentrations between the SLB and CAB used a two-tailed Student’s Mest 
where the maximum probability of a type-1 error was set to a  = 0.05. Therefore statistical 
significance o f variance was set at p  < 0.05. Variables that did not approximate the 
normal distribution using the Shapiro-Wilk’s W test (p < 0.01; Zarr, 1999) were logio- 
transformed to meet the assumptions of the statistical tests. Summary statistics for any 
analytes were computed only if  at least 50% of the samples had concentrations above the 
MLOQ. Any sample concentrations within such a group below the MLOQ were assigned 
a random value between 0 and the [MLOQ]. The variance due to the effect o f differences 
in individual extractable lipid content in liver tissue on OC, PCB, PBDE and MeSOa- 
PCB concentrations was minimized by using lipid-normalized concentrations (ng/g lipid 
weight). Age, sex and sampling date were examined as possible variables affecting 
organohalogen concentrations in animals from both beluga whale populations.
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3.3 Results
3.3.1 PCBs and PCB metabolites
Preliminary examination o f the data showed no clear relationship between any 
organohalogen compound class and either age, sex or sampling date, with only two 
exceptions. First, a negative correlation (r2 = 0.76) between X-PBDE and age was found 
in the SLB, as has been shown in pilot whale adipose tissues (Lindstrom et al., 1999). A 
negative relationship between X-PBDE and sex was also seen in SLB, but it was likely 
due to a third variable- age, because the only two adults were both males. Second, a 
positive correlation was found for X-MeSCVPCB and age (r2 = 0.61) in SLB. Given the 
small number o f samples obtained overall (n = 6  for SLB and n = 11 for CAB), the 
heterogeneity o f the samples (in age, sex) and the lack of relationship based on sub­
classification (age, sex, collection date) in general, results were evaluated only on a 
population basis (SLB cf. CAB).
The mean organohalogen contaminant and metabolite concentrations were 
generally higher in the liver tissues o f  beluga whales from the St. Lawrence Estuary than 
in those from western Hudson Bay (Table 3.1). Although the concentration ranges for all 
contaminant classes were large, the mean X-PBDE, X-PCB, X-HO-PCB and X-MeSC>2- 
PCB concentrations were all significantly higher (p < 0.05) in SLB than in CAB samples. 
The mean X-PCB and X-DDT concentrations were 16 times, X-HO-PCBs 22 times and 
X-MeSCVPCBs 49 times higher in SLB than in CAB. However, in both populations, X- 
HO-PCB metabolites comprised < 0.2% of X-PCBs. X-MeSCh-PCB were 49-fold higher 
in SLB and comprised a larger contribution (11% cf. 4%) to the total PCB levels than in
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Table 3.1. The arithmetic mean (± S.E.) and range of concentrations (ng/g, lipid weight) 
o f major neutral and phenolic organohalogen compound classes in the liver tissues of 
beluga whales from the St. Lawrence River Estuary (collected from 2000 to 2003) and 
from Western Hudson Bay (collected in 2002 and 2003).
Analyte Class St. Lawrence River Estuary 
(n = 6 )
Western Hudson Bay 
( n = l l )
% Lipid 3.2 ±0 .6  (0.7-5.1) 3.4 ± 0.2 (2.0-4.9)
X-PBDE 2210 ±656 (246-3030)* 53 ± 16(2-183)
X-HO-PBDE <0.5 <0.5
X-PCB 31 937 ±6498 (1351-45392)* 1939 ±436 (320-4501)
I-HO-PCB 65 ± 22 (<0.5-145)* 3.1 ±0.5  (<0.5-5)
X-M eS02-PCB 3801 ± 1322(18-8629)* 77 ±23 (18-251)
X-DDT 4536 ± 1152 (39-7832)* 284 ±81 (41-913)
3-MeS02-/y?’-DDE 84 ± 44 (<0.5-256) 2 2  ± 1 0  (2 - 1 1 0 )
OCS 11 ±4(<0.5-23) 1.4 ±0.3 (<0.5-3.5)
4-HO-HpCS 1.5 ± 0.4 (<0.5-4) 0.5 ± 0 (O .5-0.5)
X-HCH 74 ± 18(7-136) 45 ± 8  (12-97)
X-CHL 2355 ± 551 (56-3857)* 808 ± 153 (181-1556)
Heptachlor epoxide 193 ± 59  (2-339) 123 ±25  (<0.5-251)
X-Mirex 47 ± 10(0 .5-77)* 0.59 ± 0.04 ( 0 . 5-0.7)
HCB 121 ±24(22-174) 144 ± 30 (9-264)
Dieldrin 757 ± 187 (34-1222)* 275 ± 49 (0 .5 -500)
* Significantly higher (p < 0.05) in SLB relative to CAB.
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CAB liver tissues. X-MeSCh-PCBs were 58 and 27 times greater than X-HO-PCBs in 
SLB and CAB, respectively. The highest mean concentrations in SLB were in the order 
of X -P C B  > X-DDT > X-MeSCh-PCB, and in CAB the order was X-PCB > X-Chlordane 
> X-DDT. Regardless of males and females, for the CAB the highly recalcitrant CB153 
showed strong correlations with X-PCBs, X-PBDEs and X-MeSCVPCBs, but not with 
X-HO-PCBs (Fig. 3.1). With a lower number o f samples and with five individuals 
exceeding 30,000 ng/g X-PCB, it was not surprising that similar (to CAB) and 
statistically significant relationships between X-PCB and X-MeSCh-PCB, X-PBDE or X- 
HO-PCB concentrations were not found for SLB (not shown).
PCB congeners in the tri- to nona-chlorinated isomer classes were detected. 
Taking the ratio o f individual congener concentrations to the concentration o f the slowly 
metabolized CB153 showed differences in the PCB congener profiles in liver of 
individuals from the two populations. CAB exhibited significantly (p < 0.05) larger ratios 
for tri- to hexa-chlorinated congeners than SLB, whereas SLB showed significantly larger 
ratios for hepta- and octa-chlorinated congeners (Fig. 3.2A). When grouped according to 
the metabolic classification scheme for marine mammals (Boon et al., 1997), SLB 
showed larger ratios to CB153 o f the recalcitrant Group I and II PCB congeners (Table 
1 .1 ; Fig. 3.2B). However, SLB appeared to have depleted ratios o f some Group III and IV 
congeners relative to CAB liver tissues.
X-HO-PCB concentrations were low in comparison to other organohalogens 
(Table 3.1). In SLB, 18 penta- to hepta-chlorinated HO-PCB congeners were found,
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Fig. 3.1. Correlations between the concentrations (ng/g lipid) o f CB153, X-MeSC>2 -PCB, 
X-PBDE and X-HO-PCB with X-PCB (ng/g lipid) in the livers of beluga whales from the 
Canadian Arctic (n = 11).
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Fig. 3.2. The ratios of the arithmetic means o f PCB congener to CB153 concentrations in 
the livers o f St. Lawrence (black bars, n = 6 ) and Canadian Arctic beluga whales (white 
bars, n = 11) (A) arranged by Cl-substitution pattern and (B) arranged by metabolic 
classification (Boon et al., 1997). Significant differences (p < 0.05) between the two 
populations are marked with asterisks. Error bars represent ± S.E. of the mean.
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though penta-chlorinated congeners comprised > 90% of the X-HO-PCB (Fig. 3.3). 4- 
HO-CB107 and 4-HO-CB112 were the dominant congeners detected in the St. Lawrence 
population. In CAB, only one HO-PCB congener was quantifiable, i.e. 4 ,-HO-CB120. 
The concentration o f 4 ’-HO-CB120 was significantly higher ip < 0.05) in CAB relative 
to SLB. A probable metabolite o f OCS (Sandau et al., 2000), low levels o f 4-HO-HpCS 
were also detected in the phenolic fraction from SLB and CAB liver tissues (Table 3.1).
4-HO-HpCS constituted 15% of the OCS concentration in SLB, but less than 1% of the 
total in CAB. Furthermore, 4-HO-HpCS concentrations were 3% and 17% of the X-HO- 
PCB concentrations in SLB and CAB, respectively.
E-M eS0 2 -PCB concentrations in SLB and CAB were among the highest relative 
to other organohalogen classes, with the exception o f X-PCB and X-DDT. Tetra- to hexa- 
chlorinated MeSOa-PCBs were detected in both populations, but significant differences 
in the ratios o f individual MeS0 2 -PCB congeners to CB153 concentrations between the 
SLB and CAB were observed for a number of congeners (Fig. 3.4). The concentration 
ratios were higher for SLB and indicated different congener patterns between the two 
populations. The dominant congeners were 3’- and 4 -MeSO2-CB1 0 1 , -CB49 and -CB87 
in beluga whale liver tissue from both populations. A methylsulfonated metabolite of 
DDT, 3 -MeS0 2 -p,p '-DDE, was also found at higher but insignificantly different (p<0.05) 
levels in SLB relative to CAB.
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Fig. 3.3. The arithmetic mean concentrations of individual HO-PCB congeners in the 
liver tissues o f beluga whales from the St. Lawrence Estuary (black bars, n = 6) and from 
the Canadian Arctic (white bars, n = 11). HO-PCBs were determined as MeO-PCB 
derivatives (see Materials and Methods). Significant differences (p < 0.05) are marked 
with asterisks. Error bars represent the ± S.E. o f the mean.





Cl4 C l5 Cl6 Cl7
Fig. 3.4. The ratio of the arithmetic mean of the individual MeSCL-PCB congener to 
CB153 concentrations in the livers of beluga whales from the St. Lawrence (black bars, n 
= 6) and the Canadian Arctic (white bars, n = 11). Significant differences (p < 0.05) 
between the two populations are marked with asterisks. Error bars denote ± S.E. o f the 
mean.
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3.3.2 PBDEs and HO-PBDE metabolites
X-PBDE concentrations were 42-fold and significantly higher (p < 0.05) in the 
liver tissues o f SLB than in CAB (Table 3.1). In SLB, the juvenile animals had an order 
o f magnitude higher concentrations then the two adult males, in comparison to the PCBs 
where no obvious differences were observed. Nonetheless, X-PBDE levels were 14- and 
2-fold lower than X-PCB and X-DDT in SLB, whereas they were 36 and 5 times lower in 
CAB, respectively. PBDE congener profiles showed similarities in the liver tissues of 
beluga whales from both populations, with BDE47 and BDE99 concentrations 
comprising about 40% and 20%, respectively, o f the X-PBDE in SLB and CAB (Fig. 
3.5). However, BDE100 made up almost twice as much of the X-PBDE in CAB than in 
SLB. BDE153 and BDE154 made a significantly lower proportion o f X-PBDE in CAB 
versus SLB. The minor congeners BDE28, BDE138 and BDE183 were only detected in 
SLB. BDE49 was not detected in samples from either population. Other unidentified 
brominated peaks were also detected but not identified in the neutral, PBDE-containing 
fractions in liver of animals from both populations.
Although the levels o f HO-PBDEs were below the limit o f quantification (0.01 
ng/g wet weight, S/N = 10) in all samples from SLB and CAB, some compounds were 
nonetheless detectable (3 < S/N > 10) in the phenolic fractions extracted from some liver 
samples of animals from both populations. Only four HO-PBDEs could be identified: 25- 
HO-BDE68, 6-HO-BDE47, 3-HO-BDE47 and 4’-HO-BDE49 (Fig. 3.6).
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Fig. 3.5. The arithmetic mean fractions (represented as percentage) o f individual PBDE 
congener to 2-PBDE concentrations in the liver tissues o f St. Lawrence (black bars, n = 
6) and Canadian Arctic (white bars, n = 11) beluga whales. Significant differences (p < 
0.05) between the two populations are marked with asterisks. Error bars represent ± S.E. 
of the mean.
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Fig. 3.6. GC-MS(ECNI)(TIC) chromatograms (SIM anions: 79B f and 8lBr") o f (A) MeO- 
PBDE external standard mixture and (B) the derivatized halogenated phenolic fraction 
extracted from the liver tissues of an adult female beluga whale from the Canadian 
Arctic. Peak identification is as follows: 1 -  6’-HO-BDE17, 2 = 2’-HO-BDE28 (internal 
standard, IS .), 3 = 4’-HO-BDE17, 4 = 6 ’-HO-BDE49, 5 = 2’-HO-BDE68, 6 = 6-HO- 
BDE47, 7 = 3-HO-BDE47, 8 = 5-HO-BDE47, 9 = 4’-HO-BDE49, 10 = 4-HO-BDE42, 
11 -  6-HO-BDE90, 12 = 6-HO-BDE99, 13 = 2-HO-BDE123, 14 = 6-HO-BDE85 and 15 
= 6-HO-BDE137.




















The toxicodynamics of anthropogenic organohalogens, especially o f emerging 
contaminants like PBDEs, in marine mammals remains unclear. Metabolic processes, 
which can be selectively induced and inhibited by organohalogen exposures, may 
facilitate detoxification and excretion of these PBTs. There are, however, a growing 
number o f  studies suggesting the formation of persistent secondary compounds, through 
biotransformation processes, may be o f importance in the toxicity o f PBTs to not only 
marine mammals, but also humans and wildlife in general. Previously, it was 
immunologically shown that in liver tissues o f SL and Arviat (western Hudson Bay) 
beluga whales there are cross-reactive isoforms o f several CYP450 monooxygenases and 
UDGPT (McKinney et al., 2004). For the Arviat animals, there was also corresponding 
catalytic activity. In this study, we determined the liver concentrations precursor (parent) 
PCBs and PBDEs, and found relatively lower levels o f HO-PCB, MeSOa-PCB and 
putative HO-PBDE metabolites in two populations of beluga whales. However, there 
were clear differences in precursor and metabolite levels between the two populations.
3.4.1 PCBs
Different congener profiles o f parent PCBs between populations and species o f 
marine mammals (e.g. Bemt et al., 1999; Metcalfe et al., 1999, 2004; Hobbs et al., 2002) 
suggest variability in metabolic capacities and/or exposures. St. Lawrence beluga whales 
generally have higher levels o f OC contaminants than belugas from Arctic regions in 
Canada due to historical exposures (Metcalfe et al., 1999). Here, we show variation in the 
levels of PCB congeners between SLB and Arviat belugas, in agreement with one
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previous study quantifying PCBs in the livers of St. Lawrence and Hendrickson Island 
(Canadian Arctic) beluga whales (Metcalfe et al., 1999), indicative o f higher exposures to 
OCs in SLB. The SLB and CAB adult male beluga whales we sampled had liver E-PCB 
concentrations o f 41 444 and 3323 ng/g lipid weight, respectively, in good agreement 
with, but slightly lower than, 53 884 and 4894 ng/g lipid weight found for such 
individuals in the Metcalfe et al. (1999) study, sampled around 10 years earlier. Z-PCB 
concentrations (lipid weight) in the present adult male SLB liver samples were somewhat 
lower than those found in blubber o f dead males from this population between 1982 and 
1994 (Muir et al., 1996b), but somewhat higher than those from live biopsied males from 
1994 to 1998 (Hobbs et al., 2003). Greater representation o f higher chlorinated congeners 
in the Z-PCB concentrations indicated their persistent/accumulative nature in comparison 
to lower chlorinated congeners in both populations.
After correction to a slowly metabolized congener (CB153), different congener 
profiles emerged in the liver tissues according to metabolic class between the SLB and 
CAB. Higher ratios of Groups I and II PCBs in SLB versus CAB are likely related to 
differences in exposure; higher-chlorinated compounds are less volatile and tend to be 
less represented in remote regions such as the Arctic. In contrast, depleted ratios of 
Groups III and IV PCBs in SLB cf. CAB may more likely be due to increased 
metabolism as a function of induced phase I (e.g. CYP1A) and possibly phase II 
biotransformation activities in more exposed populations (Nyman et al., 2003).
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3.4.2 PBDEs
To our knowledge, this is the first report o f PBDEs in liver tissues o f any species 
o f whale. The hepatic PBDE congener profiles in both populations were very comparable 
to that found in the blubber tissues o f SLB (Lebeuf et al., 2004). One exception was the 
elevated percentage of BDE100 (to total [PBDE]) in CAB vs. SLB. Comparison of 
PBDE levels in this study to those found in previous studies must be interpreted with 
caution, as PBDE levels in the North American environment and biota are rapidly 
increasing (Betts, 2001). Liver X-PBDE concentrations (74 ng/g lipid, sampled in 2003) 
in western Hudson Bay male belugas in this study were higher than those found in male 
Cumberland Sound (eastern Canadian Arctic) beluga (16 ng/g lipid, sampled in 1997) 
and male Kugmallit Bay (western Canadian Arctic) beluga (17 ng/g lipid, sampled in
2001) adipose tissues (Law et ah, 2003). This may be due to temporal differences in 
PBDE concentrations or to the closer proximity o f Hudson Bay to possible sources at 
lower latitudes. This finding is less likely due to a preference of PBDEs for liver tissue as 
we found similar lipid-corrected concentrations o f X-PBDE in the liver tissues o f our two 
St. Lawrence adult male belugas (average = 389 ng/g lipid) sampled in 2001 as Lebeuf et 
al. (2004) reported in the blubber tissues o f five adult St. Lawrence belugas (average 541 
ng/g lipid) sampled in 1999. Boon et al. (2002) also found no preference for PBDEs in 
liver versus blubber tissues o f harbour seals (Phoca vitulina) and harbour porpoises 
{Phocoena phocoena). In contrast, lipid-corrected concentrations o f some PCBs (<ortho- 
unsubstituted congeners) may be elevated in liver tissues, supposedly to due interactions 
with CYP1A enzymes (van den Berg et al., 1994).
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PBDEs exhibit large variation between congener profiles in the technical mixture 
and profiles in the environment as well as in biota (Hites, 2004). Differences in PBDE 
congener profiles between species in the same food chain has also been reported (Boon et 
al., 2002; Welkers et al., 2004), which is suggestive o f PBDE biotransformation 
potential. Although we and others have found that PBDE concentrations are still lower in 
beluga whales than PCBs, as PBDE levels increase in wildlife, the need for further 
research on PBDE metabolism is necessitated.
3.4.3 Hydroxylated PCBs and PBDEs
Both PCBs and PBDEs may be metabolically transformed with potential 
biological activity to hydroxylated metabolites (Letcher et al., 2000a; Hakk and Letcher, 
2003). In this study, we detected retained HO-PCB and HO-PBDE congeners, and PCP 
and 4-HO-HpCS, in the liver o f beluga whales from two Canadian populations. Most 
reports have focused on blood plasma as these hydroxylated compounds have perhaps the 
highest affinity for this tissue due to their interactions with thyroid transport proteins 
(Letcher et al., 2000a; Meerts et al., 2000). Thus, this is the first report of these classes of 
halogenated phenolic compounds (HPCs) in a tissue other than blood in marine mammals 
or any other wildlife species. A single previous publication reported HO-PCBs in human 
liver and adipose tissues (Meironyte-Guvenius et al., 2002). HO-PCBs, HO-PBDEs, PCP 
and 4-HO-HpCS may be retained in the liver, in part, because o f fatty acid conjugation 
and/or interaction with hepatic proteins/enzymes. PCP and a hydroxy-DDT were both 
shown to be conjugated by liver fatty acids in rats (Leighty et al., 1980, 1982). However, 
it is possible that the presence of HPCs in liver is a function of blood residues (Bergman
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et a l, 1994). In addition to being protected by protein binding interactions, the lifetime of 
HO-PCBs in the liver may also be due to inhibition o f enzymes mediating conjugation 
processes. HO-PCBs have demonstrated strong (inhibitory) interactions in vitro with 
phase II intestinal biotransformation enzymes in catfish (Ictaluris punctatus), particularly 
glucuronosyl transferases (van den Hurk et al., 2002). In addition, in vitro inhibition o f 
thyroxine sulfation by HO-PCBs has been shown in rats (Schuur et al., 1998).
Elevated levels o f HO-PCB metabolites were found in the livers o f belugas 
inhabiting the estuary downstream o f the contaminated St. Lawrence River in comparison 
to those from the relatively less contaminated western Hudson Bay region. It is unlikely 
that the HPCs present in beluga whale liver may be due to food chain bioaccumulation. 
With differences in dietary exposure, HO-PCBs were reported in fish (major constituents 
o f beluga whale diets) from marine (Baltic Sea) and freshwater (Great Lakes) systems 
(Asplund et al., 1999; Campbell et al., 2003; Li et al., 2003). Metabolism of the precursor 
congeners is more than likely the mechanism. Differences in cytochrome P450 and/or 
phase II conjugative biotransformation activities exist between animals in the 
differentially exposed populations. This has been shown qualitatively by immunological 
assessment for the present beluga whales (McKinney et al., 2004). Grey (Halichoerus 
grypus) and ringed (Phoca hispida baltica) seals from the heavily polluted Baltic Sea 
exhibited higher hepatic CYP1 A-mediated EROD (7-ethoxyresorufin O-deethylase) 
activities than those from reference sites, which were significantly correlated with liver 
PCB loads (Nyman et a l ,  2003). Evidence for differential metabolic capacity between the 
two Canadian beluga populations also comes from the fact that HO-PCBs and MeS02- 
PCBs were at higher concentrations relative to PCBs in SLB relative to CAB; X-HO-
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PCB and X-MeSCVPCB levels were 22- and 49-fold higher in SLB than in CAB, 
whereas X-PCB were only 16-fold higher in the former population than in the latter. The 
higher exposure o f SLB to enzyme-inducing contaminants is consistent with higher PCB 
metabolite to PCB ratios.
Although 18 HO-PCB congeners were found in SLB, only 4’-HO-CB120 was 
detectable in CAB. The concentrations of 4’-HO-CB120 were weakly and positively 
correlated with both testosterone to androstenedione conversion (r2 = 0.48, p  = 0.03) and 
UDPGT (r2 = 0 .41, p  -  0.05) activities in catalytically viable microsomes from these 
same CAB, reported previously (McKinney et al., 2004). However, androstenedione and 
UDPGT and 6p-testosterone hydroxylase activities also co-varied significantly. In rats, 
4’-HO-CB120 and 4-HO-CB107 are metabolically formed from CB118 (Sjodin et ah, 
1998). CB118 is one o f the major PCB congeners in both the SLB and CAB hepatic 
tissues we studied, and thus could be a precursor of these retained metabolites. 4-HO- 
CB107, which can also be formed from CB105 in rat (Sjodin et ah, 1998), was one o f the 
dominant congeners in SLB, but it was not detected in CAB. Closer examination of the 
structures o f the HO-PCBs identified, reveals that roughly half (4-HO-CB165, 3’-HO- 
CB180, 4-HO-CB187 and 4-HO-CB193) come from parent PCBs with no ortho-meta or 
meta-para vicinal hydrogen-atom pairs (Fig. 3.2). Although Group I PCBs (Fig. 3.2B) 
are “resistant” to degradation and thus have a slow rate o f metabolism, biotransformation 
to these HO-PCB congeners still occurs. HO-PCB congeners o f metabolically “resistant” 
Group I PCB congeners have also been found in human liver (Guvenius-Meironyte et al.,
2002), human plasma and grey seal blood (Bergman et ah, 1994), polar bear plasma
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(Letcher et al., 2004; Sandala et al., 2004), bowhead whale plasma (Hoekstra et al., 2003) 
and in various fish species (Li et al., 2003). Nonetheless, lower levels o f HO-PCBs 
derived from Group I PCB congeners were found in the belugas relative to the other 
quantifiable HO-PCBs. These other HO-PCBs must be derived from precursor PCB 
congeners with 2 or less ortho-chlorines and ortho-meta unsubstituted sites, and some 
with meta-para vicinal H-atom pairs as well (Groups II, III or IV). However, none o f the 
retained HO-PCBs could have come from parent PCBs with only meta-para 
unsubstituted sites on the biphenyl ring. It has been proposed that HO-PCB formation 
from meta-para chlorine-unsubstituted PCBs via the arene epoxide intermediate must 
compete with phase II conjugation o f the epoxide with glutathione and subsequent 
formation o f MeS02-PCB metabolites (Letcher et al., 2000a).
Although this study does establish the presence of HO-PBDEs in beluga liver 
tissues (and/or residual blood), low concentrations o f HO-PBDEs prevented a 
comparison o f the congener profiles and levels between the two differentially exposed 
populations o f beluga whales. Whereas X-HO-PCB comprised around 10% or more of X- 
PCB in human liver tissue (Meironyte-Guvenius et al., 2002) and represented an even 
greater proportion in blood tissues o f other mammals (Bergman et al., 1994; Hoekstra et 
al., 2003; Sandala et al., 2004), X-HO-PCB/X-PCB in the present beluga liver tissues was 
< 0.2%. This suggests lower metabolic capacity o f beluga whales to form and retain HO- 
PCBs, and/or greater capacity to deplete HO-PCBs by phase II conjugation processes. By 
extension, the same is likely true for HO-PBDEs in beluga whale. There is also some 
evidence that orfAo-substituted HO-PBDEs may be natural products in marine
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environments (Haglund et al., 1997). In Chapter 4, in vitro studies on parent PBDEs 
directly address the possibility o f phase I CYP-mediated PBDE biotransformation (and 
possible HO-PBDE formation) in beluga whale. Perhaps time trend studies examining 
possible correlations between HO-PBDE levels and the rapid rise o f PBDEs in biota 
would also distinguish between natural and (metabolic products of) anthropogenic 
sources.
3.4.4 Methyl sulfone PCBs and DDEs
In the only other study examining MeS02-PCBs and HO-PCBs in liver tissue, 
Meironyte-Guvenius et al. (2002) reported that in Swedish humans the £-MeS02-PCB 
and Z-HO-PCB concentrations were similar. In contrast, we found that X-MeSC»2-PCB 
concentrations were much higher in beluga liver than ZXHO-PCB. Liver Z-MeSC^-PCB 
concentrations were much higher (49-fold) in SLB compared to CAB, and we similarly 
found higher levels o f PCBs in individuals from the former population. Letcher et al. 
(2000b) found comparable levels o f MeSCh-PCBs in the adipose tissues o f SLB and 
CAB in a previous study, but also found similar levels o f PCBs between beluga whales 
from the two populations. This may be due, in part, to the different sampling techniques. 
In this study, SLB liver tissues were taken from dead stranded animals. In Letcher et al. 
(2000b), adipose tissues taken by biopsy from live animals. As mentioned previously, 
Hobbs et al. (2003) found that levels o f highly chlorinated PCBs were lower in biopsied 
animals than those previously found for dead animals.
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It has been demonstrated in seals that (lipid normalized) MeSCVPCB 
concentrations were higher in liver than in blubber, muscle or brain (Karlson et a l, 2000). 
A preference o f MeS02-PCBs for liver tissues is explained by specific protein binding 
(Letcher et al., 2000a). Elevated MeSCh-PCB concentrations in SLB versus CAB liver 
may be related to differences in exposures to parent PCBs or metabolites or possibly to 
elevated metabolic activities in the highly exposed SLB population. MeS02-PCBs are 
CYP2B1/2 inducers in rats (Kato et al., 1997) and CYP2B-type isozymes are ostensibly 
the CYPs involved in mediating the formation o f meta-para unsubstituted HO-PCBs, 
which are the precursors to MeS02-PCBs (Letcher et al., 1998).
3.5 Conclusions
Metabolism may play a critical role in the toxicokinetic sequence o f exposure to a 
contaminant through to eventual toxicological outcome(s) in an organism. In this study, 
we report for the first time the presence o f retained hydroxylated metabolites o f both 
PBDEs and PCBs in the hepatic tissues o f beluga whales from two differentially exposed 
Canadian populations. The more exposed St. Lawrence beluga whale population showed 
higher levels o f HO-PCB and MeS02-PCB metabolites as well as generally elevated 
concentrations o f PCBs, PBDEs and organochlorine pesticide residues. As it has been 
reported that HO-PCB, MeS02-PCB and HO-PBDE metabolites, in addition to their 
parent compounds, exhibit estrogenic, thyroidogenic and/or neurodevelopmental 
toxicities, beluga whales, particularly from the St. Lawrence region, may exhibit 
deleterious health effects associated with these and other organohalogen pollutants.
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CHAPTER 4
Hepatic Microsomal Biotransformation of Polybrominated Diphenyl 
Ethers and Polychlorinated Biphenyls in Beluga Whale {Delphinapterus
leucas)^
4.1 Introduction
Marine mammals are exposed to persistent bioaccumulative toxic (PBT) 
substances through their diets and tend to accumulate PBTs in lipid-rich tissues (blubber) 
throughout their long life spans. Currently used as flame retardant additives in polymeric 
materials, polybrominated diphenyl ethers (PBDEs) have been reported in a limited 
number o f marine mammal species and populations (Andersson et al., 1992; Sellstrom et 
al., 1993; Haglund et al., 1997; de Boer et al., 1998; Lindstrom et al., 1999; Boon et al., 
2002; Ikonomou et al., 2002a, 2002b, 2004; Law et al., 2002; She et al., 2002; Kajiwara 
et al., 2004; Lebeuf et al., 2004; McKinney et al, 2004a; Wolkers et al, 2004). In 
cetaceans (all odontocete species), PBDEs have been found in pilot whales (Lindstrom et 
al., 1999), killer whales (Rayne et al., 2004), beluga whales from the St. Lawrence
^M.A. M cKinney, S. De Guise, A. Arukwe, P. Beland, D. Martineau, R.J. Letcher. In preparation.
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(Lebeuf et al., 2004; McKinney et al., 2004a) and Arctic regions (Law et al., 2003; 
McKinney et al., 2004a; Wolkers et al., 2004) and in deep-sea inhabiting sperm whales 
(de Boer et al., 1998). BDE47 was found to be the dominant congener, but lesser amounts 
o f BDE99, BDE100, BDE153, and BDE 154 were also found in these whales, a similar 
pattern to that in most other humans and biota sampled to date (Hites, 2004).
Similar to recent temporal studies on PBDE concentrations in North American 
humans (Schecter et al., 2003; Ryan, 2004), and in Great Lakes and Pacific coast fish 
(Ikonomou et al., 2002a; Law et al., 2003), beluga whales (both those inhabiting the St. 
Lawrence Estuary and the Canadian Arctic regions) show temporally increasing PBDE 
levels (Stem and Ikonomou, 2000a,b, 2001; Law et al., 2003; Lebeuf et al., 2004). PBDE 
concentrations in tissue (liver and blubber) of beluga whales are lower, but increasingly 
comparable to the already present body burdens of more environmentally established 
contaminants like polychlorinated biphenyls (PCBs) and organochlorine (OC) pesticides 
(Metcalfe et al., 1999; Letcher et al., 2000a; Hobbs et al., 2003; McKinney et al., 2004a). 
Multiple pathologies exhibited in the threatened (COSEWIC, 2004) St. Lawrence beluga 
whale population have been associated with PCB and OC exposure (De Guise et al., 
1995), although PBDE exposure may be contributing to these contaminant-effects 
associations.
Phase I cytochrome P450 (CYP) and phase II conjugative enzymes, mainly 
operating in the liver, catalyze the metabolism of many endogenous and xenobiotic 
compounds in organisms including marine mammals (Goksoyr and Forlin, 1992; 
Stegeman and Hahn, 1994; Lewis et al., 1998). A variety of CYPs, as well as epoxide 
hydrolase and UDP glucuronosyl transferase enzymes, that have been found in beluga
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whale (White et al., 1994, 2000; McKinney et al., 2004b) may influence the capacity o f 
these cetaceans to detoxify and eliminate contaminants. As well, these catalytic processes 
can result in the formation of toxic, retained and/or persistent metabolites from primary 
organohalogen contaminants, e.g., methyl sulfonyl- (MeSCV) and hydroxylated- (HO-) 
PCBs (Bergman et al., 1994; Letcher et al., 2000b; McKinney et al., 2004a). Exposure to 
HO-PCB metabolites has resulted in thyroidogenic effects, altered vitamin A levels, and 
inhibition o f phase II sulfation and glucuronidation in experimental organisms (Brouwer 
et al., 1986; Schuur et al., 1998; van den Hurk et al., 2002). MeS0 2 -PCB treatment led to 
altered enzyme activities and thyroid hormone levels in rats (Kato et al., 1995a,b; 1998), 
as well as reproductive toxicities in mink (Lund et al., 1999).
In the case o f PCBs, congener patterns in tissues from prey and predator species 
in relation to the expression and activities o f CYP enzymes has given rise to a metabolic 
classification scheme for marine mammals (Boon et al., 1997). In beluga whale from 
Canadian populations, oxidative metabolism of PCBs has also been evidenced by the 
finding of HO- and MeS02-PCBs in the liver and/or adipose tissues (Letcher et al., 
2000a; McKinney et al., 2004a).
In general, the toxicokinetics o f PBDEs and other BFRs of environmental 
importance is not nearly as well understood as PCBs in wildlife and in particular in 
marine mammals (Hakk and Letcher, 2003). Regardless, apparent metabolites of PBDEs, 
the HO-PBDEs, have been found in the liver tissues of beluga whales (McKinney et al., 
2004a), in the blood plasma o f a killer whale (Bennett et al., 2003), and in some fish 
species (Asplund et al., 1999; Marsh et al., 2004; Letcher et al., 2003). In addition, MeO- 
PBDEs have been reported in ringed seal, beluga whale and fish (Haglund et a l, 1997;
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Asplund et al., 1999; Marsh et al., 2004; Wolkers et al., 2004). Direct evidence o f PBDE 
metabolism to HO-PBDE metabolites was reported in laboratory rodents after oral 
administration o f the congeners BDE47, 99, 100 and 209 (6 m  and Klasson-Wehler, 
1998; Hakk et al., 2002; Morck et al., 2003; Hakk et a l, 2004). Catalytic debromination 
o f higher brominated to lower brominated BDE congeners has also been recently 
reported. In the gut o f dietary exposed common carp (Cyprinus carpio), within 2 hrs of 
exposure, debromination of BDE209 to octabromo- and nonabromo-BDE congeners, 
BDE 183 to BDE 154, and BDE99 to BDE47 was shown (Stapleton et al., 2004a,b,c). HO- 
PBDEs have shown estrogenic and thyroidogenic activities in experimental organisms 
(Meerts et al., 2000, 2001). However, it has yet be demonstrated for beluga whale, or any 
Arctic marine mammal, that the presence o f HO-PCB and HO-PBDE congener residues 
in tissue are definitively metabolic products o f PCBs and PBDEs, rather than having have 
accumulated through the diet from anthropogenic or, in the case o f HO-PBDEs, natural 
origins.
Ethical obstacles generally prevent organohalogen dosing studies in marine 
mammals, but in vitro assays provide a viable alternative. The contaminant(s) o f interest 
can be incubated with prepared sub-cellular liver fractions and metabolic activity can 
examined by monitoring depletion o f the parent compound(s) and/or formation o f 
metabolites (Murk et al., 1994; Boon et al., 1998; de Boer et al., 1998; Letcher et al., 
1998; White et al., 2000; van Hezik et al., 2001; Li et al., 2003a). In this study, we 
examine and compare the metabolism of PBDE and PCB congeners of environmental 
significance and where residues o f associated HO-PCBs and HO-PBDEs have been 
detected previously (McKinney et al., 2004a) in an in vitro system using the catalytically-
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viable, hepatic microsomes of Canadian beluga whale. We assess the hypothesis that 
biotransformation plays a role in the fate and bioaccumulation o f PCBs and PBDEs in 
beluga whale via 1) CYP mediated oxidative biotransformation resulting in the formation 
of HO-PCB and -PBDE metabolites, and 2) catalytic debromination o f higher brominated 
to lower brominated BDE congeners.
4.2 Materials and Methods
Mixed congener assays (MCA) and individual congener assays (ICA) were 
performed to study both PBDE and PCB metabolism (Table 4.1). PCBs used in the MCA 
were chosen as representative congeners o f PCB metabolic groups, according to the 
metabolic classification proposed by Boon et al. (1997). As structure-activity 
relationships for the oxidative metabolism of PBDEs in marine mammals are unknown, 
the suite o f PBDEs in the MCA represented environmentally relevant congeners ranging 
from di- to hepta-bromodiphenyl ethers. PBDE and PCB congeners that were either (1) 
significantly biotransformed in the MCA, (2) metabolized in rodent studies (e.g. Om and 
Klasson-Wehler, 1998; Hakk et al., 1999), and/or (3) were putative parent compounds of 
HO-PBDE and -PCB congeners found previously as residues in beluga livers (McKinney 
et al., 2004a), were then chosen for further studies to monitor individual PBDE/PCB 
depletion and possible metabolite formation in beluga whale via the ICA.
4.2.1 Sampling, microsome preparation and protein and catalytic activity determinations 
A healthy adult male beluga whale (CA10, Table 2.1) was caught on 9 August 
2004 during a native subsistence hunt near Arviat, Nunavut in western Hudson Bay,
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Canada. Hepatic tissues were removed within 1 hr of death and immediately stored in a 
liquid N2 dry shipper. Once transported back to the laboratory (GLIER, University o f 
Windsor), the hepatic tissues were stored for the long-term at -80  °C. Beluga whale 
microsome preparation and protein content analysis were based on previously reported 
methods (Bradford, 1976; Nilsen et al., 1998) and described in McKinney et al. (2004b). 
This beluga whale was selected for in vitro metabolism studies because it showed the 
most catalytically viable hepatic enzymes of all the whales captured near Arviat in the 
summers o f  2002 and 2003 (Section 4.3.1). Due to experimental constraints and the fact 
that CA10 showed qualitatively similar phase I enzyme expression as other Canadian 
Arctic as well as St. Lawrence belugas (McKinney et al., 2004b), biotransformation was 
investigated in this individual beluga whale. Liver microsomes from pooled male Wistar 
Han rats were purchased (Gentest, Woburn, MA, USA) and used as a model mammalian 
system for PCB and PBDE metabolism in vitro in comparison to the male beluga whale 
under study.
4.2.2 Reagents
Stock solutions o f individual PBDE congeners were provided by Dr. Ake 
Bergman (Stockholm University, Sweden) and Wellington Laboratories (Guelph, ON, 
Canada). Individual PCB (in isooctane, TMP) congener standards were obtained from 
Cambridge Isotope Laboratories (Andover, MA, USA). NaH2P0 4  ® H2O and MgCl2 • 
6 H2O were obtained from Sigma-Aldrich (St. Louis, MO, USA). Disodium 
ethylenediaminetetraacetate (Na2EDTA) was obtained from Bio-Rad Laboratories 
(Mississauga, ON, Canada). NADPH regenerating system Solutions A (NADP+, glucose-
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6 -phosphate, MgCl2) and B (glucose-6 -phosphate dehydrogenase) were purchased from 
Gentest. All other reagents and solvents were o f analytical grade quality. Water was 
supplied by a Milli-Q system (Millipore, San Jose, CA, USA) equipped with a 0.22 pm 
filter.
4.2.3 Preparation o f  PCB and PBDE standards
The beluga liver microsomes were incubated with either a mixture o f PCBs or a 
mixture o f PBDEs (Mixed Congener Assay) or with individual PCB or PBDE congeners 
(Individual Congener Assay) (Table 4.1). Every mixed or individual standard contained 
CB153 as the internal standard because o f its negligible metabolic depletion in the assay 
(van Hezik et al., 2001; Li et al., 2003a). Mixed standards were prepared by combining 
the required volume of individual standards (including CB153), evaporating the mixture 
to dryness under a gentle stream of nitrogen and redissolving it in analytical grade 
acetone. Individual standards were prepared in a similar fashion. The congeners in the 
mixed standard solutions and the individual standard solutions and their concentrations 
are given in Table 4.1 A and 4 .IB, respectively. These concentrations represent a 
compromise between (1) approximating zero-order kinetics and (2 ) being low enough to 
detect metabolism (depletion) within the short time-frame of the assay.
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Table 4.1. Concentrations of PCB or PBDE congeners in the standard solutions (3 pi 





Mixed PCB Standard CB15 (4,4’-diCB) 5.3 24
CB26 (2,3’,5-triCB) 5.3 2 0
CB31 (2,4,5-triCB) 5.3 2 0
CB52 (2,2’,5,5’-tetraCB) 5.3 18
CB77 (3,3’,4,4’-tetraCB) 5.3 18
CB101 (2,2’,4,5,5’-pentaCB) 5.3 16
CB105 (2,3,3’,4,4’-pentaCB) 5.3 16
Mixed PBDE Standard BDE 15 (4,4’-diBDE) 5.0 15
BDE28 (2,4,4’-triBDE) 5.0 1 2
BDE47 (2,2’,4,4’-tetraBDE) 5.0 1 0
BDE49 (2,2 ’ ,4,5 ’ -tetraBDE) 4.9 1 0
BDE99 (2,2’,4,4’,5-pentaBDE) 4.9 8.7
BDE 100 (2,2’,4,4’,6-pentaBDE) 6.0 11
BDE153 (2,2’,4,4’,5,5’-hexaBDE) 4.9 7.6
BDE 154 (2,2’,4,4,5,6’-hexaBDE) 5.0 7.8






Individual PCB CB15 (4,4’-diCB) 7.4 33
Standards CB105 (2,3,3 ’,4,4’-pentaCB) 3.9 1 2
CB118 (2,3’,4,4’,5-pentaCB) 8.4 26
Individual PBDE BDE 15 (4,4’-diBDE) 11 34
Standards BDE28 (2,4,4’-triBDE) 5.4 13
BDE47 (2,2’,4,4’-tetraBDE) 9.9 2 0
BDE99 (2,2’,4,4’,5-pentaBDE) 9.8 17
BDE154 (2,2’,4,4,5,6’-hexaBDE) 5.6 9
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4.2.4 In vitro microsomal assay
For each contaminant standard mixture in the MCA, there were eight tubes: four 
samples (with NADPH regenerating system) and four controls (without NADPH 
regenerating system). For the ICA, three samples and three controls were run. Two 
blanks (containing only buffer and microsomes) were also run with each batch of 
samples. The microsomal assay followed the same procedure for the MCAs and the 
ICAs. A mixture (1 ml final volume) o f  buffer (80 mM NaBhPC^, 6  mM MgCl2, 1 mM 
Na2EDTA, pH 8.0), the appropriate PCB or PBDE standard (3 pi, thus only 0.3% acetone 
in the incubation mixture) and microsomal suspension (1  mg protein) were combined on 
ice. The mixtures were covered with solvent-washed foil and pre-incubated at 37 °C for 5 
min. The assay was started by the addition o f NADPH regenerating solution (50 pi of 
Solution A and 10 pi o f Solution B) sequentially to all tubes and allowed to proceed for 
90 min in a 37 °C, shaking (90 rpm) water bath. To control tubes (containing buffer, PCB 
or PBDE standard and microsomes), 60 pi o f buffer was added instead o f NADPH.
4.2.5 Extraction o f  parent and metabolite compounds
Mixed Congener Assay: For the mixed assays, depletion o f the parent PCB or 
PBDE compounds was measured. The reaction was stopped after 90 min by the 
sequential addition of 1 ml o f ice-cold MeOH to all tubes. The extraction procedure is 
based on previously published methods (Boon et al., 1998; Li et al., 2003a). In short, 
each tube was given 2 ml o f hexane, vortexed for 30 sec and centrifuged at 2500 rpm for
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5 min. The (upper) hexane fraction was collected in a new tube, and the entire procedure 
was repeated three times more. The 8  ml hexane was then treated with 0.5 ml o f 
concentrated H2SO4 to degrade/remove residual microsomal lipids. The hexane layer was 
passed through the acid layer by rocking the tube 10 times. The acid layer was then 
removed, and the hexane layer was rinsed with 8  ml o f H2O until the last aliquot was 
above pH 5 (around 6  rinsings). The tubes were capped with clean foil and stored at -20  
°C until frozen (30 min). The hexane layer was then separated from the ice and removed 
to a clean tube. A 2 ml ice-cold hexane rinsing was also transferred to the new tube. A 
0.4 ml aliquot o f TMP was then added and the extract was evaporated under nitrogen to 
around 0.1 ml. The contents were transferred to a GC vial and made up to 500 pi by 
weight with TMP.
Individual Congener Assay: In the individual assays, it was possible to monitor 
depletion o f the parent compound and formation o f potential metabolites. The incubation 
reaction was stopped after 90 min by the sequential addition o f 1 ml of ice-cold 0.5 M 
NaOH to all tubes. Internal standards for the phenolic fractions were added at this point, 
because their susceptibility or resistance to enzymatic conversion in this in vitro system is 
not known. For PBDE assays, 2 ’-HO-BDE28 (5 pi, 206 pg/pl) was added as the internal 
standard. For PCB assays, 4-HO-CB72 (5 pi, 457.5 pg/pl) was used as the internal 
standard. The separation of neutral and phenolic contaminants is based on a combination 
o f previously published methods (Hovander et al., 2002; Li et al., 2003b; Rozemeijer et 
al., 1997; White et al., 2000). After addition o f the appropriate phenolic ISTD, tubes were 
heated at 70 °C for 10 min. Then 2 ml of 6  M HC1 and 1 ml o f 2-propanol were added,
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followed by  vortexing for 1 min to break down proteins. Next, 2 ml of 1:1 methyl t-butyl 
ether (MtBE): hexanes were added. The tubes were vortexed for 1 min, then centrifuged 
at 2500 rpm  for 5 min. The (upper) organic fraction was collected in a new tube, and the 
entire procedure was repeated two more times. The organic extract containing both 
neutral and phenolic contaminants was then concentrated to around 1 ml. A 2 ml aliquot 
of KOH was added, the tube vortexed, and the (bottom) aqueous phase containing the 
deprotonated phenolics was transferred to a clean tube. This KOH partitioning step was 
repeated three times. The KOH/aqueous (phenolic) fraction was rinsed with 3 x 1 ml 
hexanes and the rinsings were transferred back to the organic (neutral) fraction. The 
neutral fraction was then eluted through hexane-saturated Na2S0 4  into a clean tube. The 
phenolics in the aqueous fraction were reprotonated by the addition o f approximately 2 0  
drops o f concentrated H2SO4 (to a pH of 2). A 2 ml aliquot o f 1:1 MtBE:hexanes was 
added, the tube vortexed, and the (upper) organic phase was transferred though 
MtBE :hexanes-saturated Na2SC>4 into a new tube. This procedure was repeated twice 
more. The phenolic extract was then evaporated to around 0.5 ml, and treated with 
diazomethane as the methylating reagent. Both fractions were evaporated to around 1 ml, 
followed by the addition o f 5 drops o f concentrated H2SO4 . After removal of the acid, the 
extract was neutralized with around 4 x 8  ml of H2O. The residual water was frozen and 
the hexane layer, followed by a 1 x 2  ml hexane rinsing, was transferred to a new tube. 
Extracts were transferred into TMP and into GC vials and made up to 250 pi by weight.
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4.2.6 Analysis o f  neutral and phenolic fractions
Neutral fractions, containing either PCB or PBDE congeners, were separated 
using an Agilent 6890 GC (Palo Alto, CA, USA) equipped with a fused silica DB-5 
column ((5% phenyl)methy!polysiloxane, 30 m x 250 pm i.d., 0.25 pm film thickness, 
J&W Scientific Inc., Folsom, CA, USA), an Agilent 7683 Series automatic liquid 
sampler and injector. Halogenated contaminants were monitored with a 63Ni pECD 
detector. Helium and 5% methane in argon were used as the carrier and makeup gases, 
respectively. For PCBs, the temperature program was as follows: 90°C for the first 1 min, 
increased to 200 °C at 15 °C/min and held for 2 min, then increased further to 280 °C at 
2.5 °C/min and held for 9 min. The total run time was 51.5 min. For PBDEs, the oven 
temperature was held at 80 °C for 2 min, increased to 290 °C at 10 °C/min and held for 
15 min, for a total run time of 38 min. HP Chemstation software was used to collect and 
process data from the GC-pECD.
The phenolic fractions were analyzed for methoxylated- (derivatized from 
hydroxylated-) PCBs or PBDEs on an Agilent 6890N GC system, with the same 
autosampler, injector and column as described for the GC-pECD, coupled to an Agilent 
5973N MSD in the electron capture, negative ionization (ECNI) mode. The MSD was 
used in selected ion monitoring (SIM) mode. The carrier and reagent gases were helium 
and methane, respectively. The GC ramping program for MeO-PCBs started with an 
initial temperature o f 80 °C for the first minute. It was then increased at a rate o f 10 
°C/min to 250 °C and held for 5 min. Another increase at 5 °C/min to 300 °C was held 
for a further 5 min. The total run time was 38 min. For possible formation o f HO-PCB (as
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MeO-PCBs) metabolites, the [M]', [M+2]~ and [M-CH3]' ions were selectively monitored. 
For CB15, di-chlorinated MeO-PCBs were monitored (ions of m/z: 252, 254, 237), as 
well as tetra-chlorinated MeO-PCBs (ions o f m/z: 322, 324, 307) to detect the ISTD. 
Further attempts to identify CB15 metabolites involved monitoring for di-chlorinated di- 
MeO-PCBs (ions of m/z: 282, 284, 267). For CB105 and CB118, tetra- (ISTD) and penta- 
chlorinated MeO-PCBs (ions o f m/z: 356, 358, 341) were monitored. For MeO-PBDEs, 
the same GC temperature profile chosen for the PBDEs was used. Negative Br-isotope 
masses o f 79 and 81 amu were monitored, as the Br‘ fragment ion has been shown to be 
highly abundant for PBDEs. A 1 pi injection, made in the splitless mode, was employed 
for all samples. The MLOQ (S/N = 10) for neutral compounds, based on the response of 
the ISTD CB153, was around 1 pg/pl. The MLOQs for derivatized phenolic metabolites, 
based on the appropriate ISTD, was around 4 pg/pl for MeO-PCBs and 1 pg/pl for MeO- 
PBDEs.
4.2.7 Data analysis
The results are reported as the fraction o f PCB or PBDE congener depleted 
(metabolized) during the 90 min time-frame o f the microsomal assay (Boon et al., 1998; 
de Boer et al., 1998; Li et al., 2003a). For each incubation (MCA or ICA), the results for 
the parent PCB or PBDE congeners were first internal standard corrected:
ratiocBi53 = peak areax (1)
peak areacei53
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where x is a PCB or PBDE congener. The ratiocsisa for the sample replicates (to which 
NADPH was added) was then compared to the ratiocBi53 for the corresponding control 
replicates (to which NADPH was not added), and the fraction o f congener x remaining 
after metabolism is:
fraction remaining = ratiocBi53 {sample) (2 )
ratiocBi53 {control)
Student’s /-tests were used to determine if the sample and control groups were 
significantly different from each other, assuming a two-tailed distribution and a 
maximum probability o f a type-I error set to a  = 0.05.
The neutral fraction recoveries are reported as the ratiocBi53 in the control divided 
by the ratiocBi53 in the standard. The recoveries o f PCB and PBDE congeners from the 
Mixed Congener Assay extraction were thus all above 75%, except for CB15, which had 
a lower, but still reproducible, recovery o f 70 ± 7 %. The PCB and PBDE recoveries 
from the Individual Congener Assay extraction were thus > 74% and > 73%, 
respectively. For the phenolic fractions, the ratio o f the peak area o f either 4-MeO-CB72 
or 2’-MeO-BDE28 in the control to that in the standard was used to calculate recoveries. 
Therefore, the HO-PCB and HO-PBDE recoveries were > 73% and > 67%, respectively.
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4.3 Results
4.3.1 Microsomal protein content and enzyme activities
The hepatic microsomes of this adult male beluga whale from western Hudson 
Bay in the Canadian Arctic showed the highest catalytic viability, as measured by 
CYPlA-mediated EROD activity, o f all beluga whales sampled during Arviat subsistence 
hunts in the summers o f 2002 and 2003 (McKinney et ah, 2004b). Putative CYP3A- 
mediated testosterone 6|3-hydroxylase and phase II UDPGT -mediated 1- 
naphthylglucuronidase rates in this individual were, though, similar to rates among the 
other belugas sampled (McKinney et al., 2004b). Elevated protein levels and CYP1A 
activity in this male are likely, in part, due to the fact that most other belugas sampled 
were females, which generally exhibit lower expression o f CYP1A than males (White et 
al., 1994). As well, a shorter time span between sacrifice and liver sampling for this 
individual than for some o f the other animals may have contributed. Overall, this 
individual exhibited reasonable induced-type (CYP1A) and constitutive-type enzyme 
(CYP3A-like) hepatic enzyme activities and was therefore an appropriate choice for the 
study of PBDE and PCB metabolism within the time constraints o f a 90 min in vitro 
assay. Table 4.2 compares some CYP enzyme activities between this male beluga whale 
and the (pooled) male rat liver microsomes.
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Table 4.2. Phase I cytochrome P450 activities in male beluga and male rat liver 
microsomes.
Enzyme Activity (pmol/mg/min) 
(CYP measured)*
Male beluga** (n = 1) Male rat*** (pooled, n = 25)














ND = not detected 
NA = not available
*For belugas, specific CYP isozymes have not been confirmed to mediate particular 
testosterone metabolism activities. CYPs indicated in parentheses are involved in this 
conversion in laboratory rodents (Arlotto et al., 1991)
**McKinney et al., 2004b.
***Gentest, Wobum, MA, USA.
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4.3.2 In vitro PBDE metabolism
Within the MCAs, beluga whale and rat liver microsomes were able to metabolize 
the PBDE mixture to different extents within the 90 min time frame of the in vitro assay 
(Fig. 4.1). Dibromo-BDEIS was completely depleted by the beluga, and 11% of BDE28 
was also metabolized to a significant extent ip < 0.05). However, the beluga whale did 
not significantly metabolize the other PBDE congeners, specifically BDE49, 99, 100, 
153, 154 and 183. In contrast, the rat biotransformed BDE28, 49, 99 and 154 (13%, 44%, 
11% and 17% depleted, respectively) to a significant extent. Thus, although both 
organisms showed comparable metabolic capacity towards tri-BDE28, the beluga more 
rapidly metabolized BDE15, and the rat exhibited more rapid metabolism of the higher 
brominated PBDE congeners (BDE 49, 99 and 154). BDE47 was also included in the 
Mixed Congener Assay; however, the MCA extraction procedure introduced either a 
peak to the chromatogram that interfered with BDE47 or BDE47 contamination itself. 
Although background correction was included, depletion results were inconsistent for 
BDE47 (data not shown). As shown later in the ICAs, the BDE47 contamination issue 
did not arise and therefore satisfactory results could be obtained for this congener.
In the ICAs, BDE 15 was again rapidly metabolized, but to a lesser extent than in 
the MCA, which is probably a consequence o f a higher treatment concentration in the 
ICA (Table 4.3). The concentration o f BDE28 used in both conditions was nearly the 
same, and the fraction of BDE28 remaining was nearly identical under both assay 
conditions (89 ± 3 %  for MCA and 90 ± 1% for ICA). In the ICAs, BDE47 was slightly 
but significantly metabolized within the 90 min period. BDEs 99 and 154 were not
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Br2 Br3 Br4 Brs Br6 Br?
Fig. 4.1. Fraction of BDE congener concentrations remaining after a 90 min in vitro 
metabolism assay using hepatic microsomes from adult male beluga whale (white bars, n 
= 1 individual) and adult male rat (black bars, 1 pool o f n = 25 individuals). The dotted 
line signifies no depletion. Significant depletion (p < 0.05) is marked by an asterisk. Error 
bars represent ± S.D. for replicate assays (n = 4).
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
137
Table 4.3. The concentration fraction remaining for PBDE congeners after metabolism in 
Individual Congener Assays (ICAs) by adult male beluga whale (n = 1). Statistical 
significance o f the depletion was reported as the j>value obtained from a Student’s t-test 
comparing ratiocBi53 between sample (n = 3) and control (n = 3) groups.
PBDE Congener Fraction Remaining ± S.D. Statistical significance (p-value)
BDE 15 37 ± 10% 0.001*
BDE28 90 ± 1% 0.007*
BDE47 95 ± 3% 0.05*
BDE99 99 ± 3% 0.8
BDE 154 103 ±5% 0.6
* Indicates statistically significant depletion.
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significantly metabolized as individual congeners, which is in agreement with the MCA
results.
The presence of HO-BDE metabolites was assessed as a result of in vitro PBDE 
metabolism. For all BDEs in the ICAs, any phenolic metabolites (e.g. mono- or di-HO- 
CBs) potentially formed from the small amounts of BDE28 and BDE47 metabolism 
observed were below the MLOQ (1 pg/|il based on ISTD). The lone exception was 
BDE15, where a single phenolic metabolite o f BDE 15 was detected in the phenolic 
extract from the microsomal incubation (Fig. 4.2). In the neutral fractions from the ICAs 
o f PBDEs, debrominated or methoxylated metabolite peaks were not observed in the 
ECD chromatograms (not shown). Even though 63% of BDE 15 was depleted, the 
phenolic BDE metabolite had a S/N ratio of only 16, where the method limit of 
quantification is set to S/N =10.  Thus, it is unlikely that BDE28 or BDE47 metabolites 
could in fact be detected given the slower rates o f biotransformation of BDE28 and 
BDE47 in comparison to BDE15.
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Fig. 4.2. Extracted ion (m/z 79) chromatograms of phenolic extracts from an in vitro 
metabolism assay o f BDE 15 with beluga whale hepatic microsomes. Samples were 
incubated with the cofactor NADPH, whereas NADPH was not added to controls. 
Comparative EIC mass chromatograms o f m/z 81 gave the same result (not shown).
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4.3.3 In vitro PCB metabolism
As for PBDEs, the beluga whale and the rat showed congener-dependent 
differences in the ability to deplete in vitro the PCB congeners present in the MCAs (Fig. 
4.3). CB15 and CB77, substrates of CYP1A, were the most rapidly metabolized (0% and 
7% remaining, respectively) PCB congeners in beluga whale, whereas 68% of CB15 and 
100% of CB77 remained after incubation with the rat microsomes. CB52 was partially 
metabolized by both rat and beluga, but the rat more rapidly depleted this Group IV, 
putative CYP2B-type substrate (49% cf. 87% remaining). Beluga whale and rat 
comparably metabolized the Group VI, mixed CYPlA/2B-type substrate tri-CB31, at 
29% and 33% depleted, respectively. Rat exhibited a greater metabolic capacity towards 
the other Group VI congener, CB26, than beluga whale 79% versus 25% depleted). 
Penta-CBlOl and penta-CB105 (Groups IV and III, respectively) were not metabolized 
significantly by either beluga whale or rat.
For beluga whale, we also ran ICAs for CB15, CB105 and CB118. Previous 
contaminant residue studies showed that some o f the major HO-PCB residues found in 
the liver tissues o f beluga whales were likely metabolites o f CB105 and CB118 
(McKinney et al., 2004a). CB118 was slowly, but nonetheless significantly 
biotransformed by beluga whale (Table 4.4). Any pentachloro-HO-PCB metabolites that 
may have formed were below the MLOQ (4 pg/pl based on ISTD). As in the MCA, 
metabolism o f CB105 was too slow to be detected in the assay (Table 4.4), and 
pentachloro-HO-PCB metabolite peaks were below the MLOQ in the phenolic fractions. 
Although CB15 was rapidly metabolized as in the MCA (although less depletion in the 
ICA is more than likely due to a higher starting concentration than in the MCA, as seen
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Fig. 4.3. The concentration fraction remaining for the PCB congeners after a 90 min in 
vitro metabolism assay using liver microsomes from adult male beluga whale (white bars, 
n = 1) and adult male rat (black bars, n = 25). No depletion is indicated by the dotted line. 
Significant depletion (p < 0.05) is indicated by dotted bars and asterisks. Error bars 
represent ± S.D. between replicates (n = 4).
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Table 4.4. The concentration f r a c t i o n  remaining for PCB congeners after metabolism in 
Individual Congener Assays by adult male beluga whale (n -  1). Statistical significance 
o f the depletion was reported as the j?-value obtained from a Student’s t-test comparing 
ra t io c B i5 3  between sample (n = 3) and control (n = 3) groups.
PCB Congener Fraction Remaining ± S.D. Statistical significance (p-value)
CB15 9 ± 2% 0.000005*
CB105 100 ±3% 0.79
CB118 98 ± 1% 0.03*
* Indicates statistically significant depletion.
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for BDE 15), no metabolite peaks could be detected measuring for methylated derivatives 
o f mono-HO-dichloro-CBs (m/z 252, 254, 237). However, when run for di-MeO- 
dichloro-CBs, a small peak was found indicating the metabolic conversion o f CB15 to a
di-HO-dichlorinated PCB metabolite.
4.4 Discussion
Reports that demonstrate the metabolic biotransformation o f PCBs in marine 
mammals are limited in number, generally focussing on only one or two specific 
congeners, i.e., CB77 and CB52 (Murk et al., 1994; White et al., 2000) or PCB congener 
mixtures (Lecher et al., 1998; Li et al., 2003a). For fish there are published reports 
showing PBDE metabolism (oxidative and debromination) in vivo (Kierkegaard et al., 
2001; Stapleton et al., 2004a,b), but there are no reports as yet for PBDEs in marine 
mammals, especially cetacean species (Hakk and Letcher, 2003). We report and compare 
the metabolism of a suite of PCB and PBDE congeners in the hepatic microsomes of 
beluga whale, and compare these to analogous results determined at the same time in rat. 
In addition to quantifying the extent o f metabolism of the parent compounds, we 
monitored the potential formation o f neutral/lipophilic and water-soluble metabolites.
4.4.1 Biotransformation o f  PBDEs in beluga whale
To our knowledge, this is the first report demonstrating direct evidence o f PBDE 
metabolism in any mammalian wildlife species (Hakk and Letcher, 2003). Our findings 
suggest a role for liver CYP isozymes in the toxicokinetics o f PBDEs in beluga whales. 
Previous studies demonstrated low, but measurable levels o f HO-PCB and putative HO-
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PBDE metabolite residues in the liver tissues of beluga whales from two Canadian 
populations (McKinney et al., 2004a). Bioaccumulative MeSCVPCB metabolites were 
found at much higher levels in the same liver samples. Within the limited time frame of 
an in vitro assay, beluga whale significantly metabolized di-BDE15, tri-BDE28 and tetra- 
BDE47. For at least one congener (BDE15), metabolism resulted in the formation o f a 
water-soluble, phenolic BDE metabolite. Since the anions o f the isotopes 79Br' and 81Br' 
were monitored, the phenolic metabolite could be singly or multiply hydroxylated, and 
could possibly contain only one bromine atom as a result o f metabolic debromination. 
One potential explanation for such a small phenolic BDE metabolite response may be the 
consequence o f full metabolic debromination with hydroxylation, which would have 
resulted in no detectable Br-anion fragments. The extent o f depletion o f PBDE congeners 
seemed to be inversely associated to the degree o f bromination o f the aromatic rings. 
Other structural factors are likely also involved, such as the position of bromine atoms 
around the aromatic rings. BDE 15, 28 and 47 have four, three and two pairs o f ortho- 
meta vicinal H-atoms, respectively, suggesting that the number o f ortho-meta 
unsubstituted sites influences metabolic capacity towards PBDEs. In further support of 
this, tetra-BDE47 was slightly but significantly depleted by beluga, whereas metabolism 
of tetra-BDE49 was not detectable. Non-ortho-HO-PBDE metabolites found previously 
in beluga liver tissues were likely metabolites of the most biologically important PBDE 
congener, BDE47 (McKinney et al., 2004a). Both BDE47 and BDE49 contain two ortho 
Br-atoms, but BDE47 contains two ortho-meta vicinal H-atom pairs, whereas BDE49 
contains one ortho-meta and one meta-para unsubstituted site. These results parallel
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PCB metabolism findings in that beluga whale show greater metabolic capacity towards 
congeners with (more) ortho-meta unsubstituted sites {Section 4.4,2; White et al., 2000).
The differential capacity of the beluga whale to metabolize the PBDEs studied 
suggests unequal CYP enzyme affinity for different congeners or perhaps the 
involvement o f various/multiple CYP isoforms. That metabolic rates of the two 
significantly depleted congeners, BDE 15 and BDE28, in the MCA assay were not slower 
than in the ICA suggests that these two congeners may not have been competing for the 
same CYP isozyme. Both the beluga whale and the rat were able to metabolize PBDEs, 
but there were clear species-specific differences in the ability to metabolize individual 
congeners. This is likely due to species differences in CYP isozyme expression and 
activities (Table 4.2; Boobis et al., 1990; Smith, 1991).
It has been suggested that PBDEs are very resistant, more resistant than PCBs, to 
metabolic degradation in marine mammals (de Boer et al., 1998). The present study 
provides evidence that for lower halogenated congeners in the same isomer class 
(specifically, di-CBs cf. di-BDEs and tri-CBs cf. tri-BDEs), beluga whale show congener- 
specific, but nonetheless comparable capacities to biotransform PBDEs and PCBs. Also, 
both PBDE and PCB congeners o f higher degrees o f halogenation are metabolized much 
less rapidly, resulting in slow or negligible metabolism in the time frame of the in vitro 
assay. Harbour and ringed seals did not exhibit detectable metabolism of highly 
chlorinated PCBs in similar in vitro assays (Letcher et al., 1998; Li et al., 2003a). 
Nonetheless, these results do not suggest the inability o f beluga whale to biotransform 
higher brominated PBDE congeners. This result more likely suggests that slower 
metabolic transformation o f such PBDEs cannot be detected within the time constraints
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of the microsomal assay, a finding similar to that for PCB metabolism {Section 4.4.2). 
Indeed, evidence o f metabolism of PBDEs o f greater degrees o f halogenation is provided 
by tissue residue analyses. HO-PBDEs have been found in the liver tissues o f beluga 
whales, which appeared to be metabolites o f BDE47 (McKinney et ah, 2004a). However, 
these HO-BDE metabolites were only detectable and not quantifiable. Low levels of 
mainly tetrabromo-mono-HO-BDE residues have been found in the blood plasma (likely 
the most important compartment for HO-PBDE retention) o f a limited number o f other 
wildlife species, i.e. Detroit River fish (Letcher et al., 2003; Valters et al., 2004) and 
snapping turtle (Chu et al., 2004), killer whale (Bennett et al., 2003) and Baltic salmon 
(Asplund et al., 1999). The source o f the observed HO-BDEs may be both metabolic or 
accumulated through diet. Additional, direct evidence for the formation of HO-PBDE 
metabolites comes from dosing studies using experimental rodents, in which metabolism 
can be measured on a scale o f days and not minutes. Hydroxylated metabolites formed 
from tetra-BDE47 (Om and Klasson-Wehler, 1998), penta-BDE99 (Hakk et al., 1999), 
penta-BDElOO (Hakk et al., 2004) and even deca-BDE209 (Morck et al., 2003) have 
been detected in rat and/or mouse.
In the only other study o f PBDE metabolism in marine mammal species, de Boer 
et al. (1998) did not detect depletion o f BDE47, 99 or 209 congeners in sperm whale 
(Physeter macrocephalus), whitebeaked dolphin {Lagenorhyncus albirostris), minke 
whale (Balaenoptera acutorostrata) or harbour seal {Phoca vitulind) using a similar in 
vitro assay. We also did not find any detectable in vitro metabolism o f congeners with 5 
or more bromine atoms, consistent with their BDE99 and 209 results. This was the case 
under both the MCA and ICA regimes in our study, suggesting that it is the slow or
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negligible biotransformation of such congeners in the assay and not competition with 
lower brominated congeners that prevented detection o f parent depletion or metabolite 
formation, as found in analogous PCB studies with Baltic grey seal (Li et al., 2003a). 
Detectable metabolism of BDE47 in the present study o f beluga whale, but not by 
organisms in the de Boer et al. (1998) study, may be due to a somewhat higher metabolic 
capacity o f  beluga towards this environmentally-dominant PBDE, although variations in 
assay conditions may also be partially responsible. In vitro BDE47 metabolism may 
suggest that retained, hydroxylated forms of BDE47 (3-HO-BDE47, 4’-HO-BDE49) 
reported at low levels in liver tissues (McKinney et ah, 2004a) are the result of 
biotransformation o f BDE47 in beluga whales.
4.4.2 Biotransformation o f  PCBs in beluga whale
CYP isoforms have previously been implicated in the metabolism of CB77 and 
CB52 in beluga whale (White et al., 2000). Here, we find that isozymes from the CYP 
family are also involved in the biotransformation o f  a number o f other PCB congeners, 
representing different metabolic classes (Boon et ah, 1997), as seen in grey and harbour 
seals (Letcher et al., 1998; Li et ah, 2003a). However, the differential rates o f metabolism 
of PCB congeners between and within metabolic groups (Fig. 4.3) imply the involvement 
o f various isozymes (e.g. CYP1A, CYP2B, CYP3A) and differential enzyme affinities 
between PCB congeners, respectively. The use o f CYP-specific chemical and/or antibody 
inhibitors would further clarify the involvement o f specific CYP isozymes in the 
metabolism of individual congeners (Letcher et ah, 1998; Kramer et ah, 2000; van Hezik 
et ah, 2001; Li et ah, 2003a).
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Previously, penta- through hepta-chlorinated HO-PCB residues were detected in 
beluga whale hepatic tissue (McKinney et ah, 2004a). However, in the present in vitro 
assay very slow to undetectable rates o f metabolism were observed for higher chlorinated 
PCB congeners (CB101, CB105 and CB118). In contrast, the di- through tetra- 
chlorinated congeners all showed significant depletion in the 90 min assay, but such HO- 
PCB metabolites o f these congeners are not generally found as tissue residues, suggesting 
that these metabolites are rapidly excreted, and do not show significant tissue retention. 
Significant metabolism of CB118 in the present study supports the hypothesis that the 
presence o f  higher-chlorinated, toxicologically active HO-PCBs as contaminant residues 
in beluga whales and in other marine mammals tissue is due to oxidative CYP 
biotransformation enzyme activities in liver tissues.
For the rapidly metabolized CB15, we were able to detect the formation o f a di- 
HO-PCB metabolite. In a previous study of CB77 metabolism in beluga whale liver, only 
mono-HO-PCB type metabolites were found, even though di-hydroxy, sulfonated and 
(mono- and di-) hydroxylated m/z were monitored (White et al., 2000). In addition, only 
mono-HO-PCBs were found in liver extracts o f fish (White et al., 1997) and laboratory 
rodents (Klasson-Wehler et al., 1989). However, CB15 is co-planar and has four, ortho- 
meta vicinal H atom pairs. It is likely that after a single (meta or para) hydroxylation, the 
mono-HO-dichloro-CB metabolites would still be somewhat coplanar (especially in 
comparison to higher chlorinated congeners used in the previous studies), and thus still 
good substrates for a second CYP 1 A-mediated hydroxylation to occur.
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4.5 Conclusions
Here we show, within the limited time frame of an in vitro microsomal 
assay, direct evidence of congener- and species-specific cytochrome P450 mediated 
metabolism o f PBDEs and PCBs in beluga whale (cf. in rat). This pathway in addition to 
other metabolic processes may influence not only the rates o f accumulation and 
elimination o f these contaminants, but also potential biological effects. Highly exposed 
populations, such as the St. Lawrence beluga whales, may exhibit elevated, induced 
biotransformation capacities, possibly resulting in the formation of retained metabolites. 
As the body burdens of PBDEs rise in beluga whales and in other sensitive marine 
mammal populations, further research is imperative to reach a better understanding of the 
kinetics and potential toxicological outcomes o f these flame retardant chemicals and their 
retained metabolites.
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The biological fate and effects of organic environmental pollutants are contingent 
upon the specific metabolic capacity of an organism. Ideally, contaminant 
biotransformation is investigated in vivo, but this research requires an alternate approach 
when marine mammals are the organisms of study. In this thesis, a “weight o f evidence” 
approach was used to assess the hepatic capacity and potential o f beluga whale to 
enzymatically biotransform PCBs and PBDEs. Three separate studies were employed to 
address this objective: (1) profiling of xenobiotic-metabolizing enzymes, (2) identifying 
and quantifying PCB, PBDE and metabolite residues and (3) assessing metabolic 
potential o f beluga towards environmentally-relevant PCB and PBDEs using an in vitro 
microsomal assay. The overall important conclusions from these studies are summarized 
here.
In the first study, immunochemical and catalytic investigations revealed that 
beluga whales exhibit analogous hepatic enzyme activity to, and homologous proteins of, 
hepatic phase I (CYP1A, CYP2B, CYP3A, CYP2E, EH) and II (UDPGT) enzymes 
known to metabolize PCBs and/or PBDEs in laboratory rodents (Chapter 2). However, 
the levels and activities o f these putative xenobiotic-metabolizing enzymes appeared to
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be dissimilar between the two populations o f differentially exposed beluga whales (St. 
Lawrence and western Hudson Bay beluga whales), as well as different from those found 
in laboratory rodents. Results suggested higher levels o f inducible (AhR-receptor 
mediated) CYP1A in St. Lawrence animals relative to their Arctic conspecifics, and this 
finding may be related to the reported toxic effects of organohalogens in the St. Lawrence 
population (e.g. immune and reproductive dysfunction, lesions). As for other cetacean 
populations, CYP2B-type activities and expression were low, supporting the hypothesis 
that low levels o f these enzymes explain, in part, higher levels o f certain contaminants in 
whales.
In the second study, retained and/or persistent toxic metabolites of PCBs, 
hydroxylated- and methyl sulfonated-PCBs, were detected in both populations (Chapter 
3). Significantly higher levels o f HO-PCBs and MeS02-PCBs were found in the St. 
Lawrence population. In addition, different parent PCB congener profiles were observed 
between the two populations. These results may be related to the (possibly induced) 
elevated enzyme activities (Chapter 2) and to the elevated exposures o f PCBs (Chapter 3) 
in the St. Lawrence population. The low to non-detectable concentrations o f HO-PBDEs 
in both populations may be due to the currently lower levels o f precursors, the PBDEs, in 
STB and CAB in comparison to PCBs; yet, the relative importance of metabolic 
formation from PBDEs versus accumulation of natural products remains unclear.
Nonetheless, in the relatively short time frame of an in vitro assay, metabolism of 
BDEs 15, 28 and 47 occurred (Chapter 4). This clearly demonstrated CYP-mediated 
oxidative biotransformation as a pathway in the toxicokinetics o f PBDEs in beluga 
whales. Hepatic metabolism of a number o f PCBs, putative substrates o f CYP1A and
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CYP2B/3A, also occurred in beluga whale in the same in vitro assay. This suggested 
similarities between PCB and PBDE metabolism in this particular cetacean species. In 
addition, water-soluble metabolites were found after incubation with the rapidly 
metabolized PCB and PBDE congeners, CB15 and BDE15. Both beluga whale and rat 
metabolized PCBs and PBDEs, however, there was a preference towards metabolism of 
ortho-meta unsubstituted congeners (of both PCBs and PBDEs) in beluga whale, whereas 
rat metabolized meta-para unsubstituted congeners more rapidly. This is in agreement 
with the low levels and activity o f CYP2B enzymes that we found in beluga whales 
(Chapter 2).
Overall, the weight of evidence from Chapters 2 to 4 indicated that beluga whales 
exhibit an exposure-influenced capacity to oxidatively biotransform PCBs. The results 
also demonstrated that congener-specific metabolism likely leads to the formation of 
retained and/or persistent and potentially toxic PCB metabolites. Beluga whales also 
demonstrate the capacity to oxidatively metabolize PBDEs. However, the importance of 
metabolism as a mechanism in fate and potential bioactivation o f PBDEs in beluga 
whales remains unclear because of the positive evidence o f PBDE metabolism in vitro 
(Chapter 4), but the very low levels o f HO-PBDEs detected as liver residues (Chapter 3). 
Regardless, beluga whales (particularly SLB) are chronically exposed to a continually 
increasingly complex mixture o f contaminants, including those yet to be identified and 
secondary bioactivated contaminants i.e. metabolites. A high incidence o f neoplasms, 
reproductive and immune dysfunction have been found in SLB, and similar toxic effects 
have been demonstrated in animals experimentally exposed to PBDEs, PCBs, other 
organohalogens and/or their metabolites. The biotransformation o f PCBs (and possibly
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PBDEs) to biologically active metabolites, demonstrated in this thesis, suggests a 
bioactivation mechanism in the possible toxic effects o f these contaminants. Moreover, 
these results provide a possible mechanistic link between high contaminant exposures 
and the health problems and pathologies documented in the endangered St. Lawrence 
beluga whale population.
The results from these studies presented herein have generated further questions, 
especially regarding the toxicokinetics o f PBDEs in marine mammals. Elevated levels of 
PCBs and other OCs in St. Lawrence beluga whales have been implicated in the various 
pathologies seen in this population. These beluga whales showed 42 fold higher 
concentrations o f PBDEs versus only 16 fold higher concentrations o f PCBs than in the 
Arctic belugas (Chapter 3). This significantly elevated exposure of SLB to PBDEs 
indicates the need to examine their toxicokinetics and potential toxicities in SLB in 
particular. There are a growing number o f studies reporting PBDE concentrations in other 
marine mammals as well, but the fate and toxicology o f these contaminants in such 
organisms remains virtually unknown. For instance, what are the CYP enzymes involved 
in PBDE metabolism? Biotransformation assays with CYP-specifxc chemical and 
antibody inhibitors would clarify the role o f different CYP isozymes. Do PBDE 
congeners induce or inhibit CYPs, UDPGTs, or GSTs in beluga whales? If so, which 
congeners are most important in mediating these effects? In addition, are the low levels 
o f HO-PBDEs due their rapid phase II conjugation and subsequent elimination, or due the 
biological persistence of, at least, certain parent PBDE congeners? How do the rates of 
HO-PBDE conjugation compare to those for HO-PCBs? These questions warrant further 
research, which may also illuminate the potential influence o f PBDEs, as well as PCBs
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and metabolites, on hormones and receptors of the endocrine system. For instance, as has 
been seen in seals, do current (and possible future) concentrations o f PBDEs influence 
the levels o f  thyroid hormones in this population? Further studies clarifying the origin(s) 
o f HO-PBDE, such as time-trend studies or !4C analysis of extracted HO-PBDEs, are also 
of importance.
The health and ultimate survival of sensitive and highly contaminated populations 
(such as St. Lawrence belugas) may be impacted by chronic exposure to PCBs and 
PBDEs and an increasingly complex mixture of other pollutants. The studies in this thesis 
and other similar research will aid in clarifying risks to marine mammals (as well as to 
other biota and humans) posed by exposure to these contaminants. A better understanding 
of the current impact and future risks o f such biological contamination will allow for 
more informed decisions as to the production and use o f chemicals with demonstrable 
PBT characteristics in the future.
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